{
  "DOI": "10.1038/s41431-020-0653-5",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-020-0653-5",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eMolecular genetic testing for congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) is offered worldwide and is of importance for differential diagnosis, carrier detection and adequate genetic counseling, particularly for family planning. In 2008 the European Molecular Genetics Quality Network (EMQN) for the first time offered a European-wide external quality assessment scheme for CAH (due to 21-OH deficiency). The interest was great and over the last years at about 60 laboratories from Europe, USA and Australia regularly participated in that scheme. These best practice guidelines were drafted on the basis of the extensive knowledge and experience got from those annually organized CAH-schemes. In order to obtain the widest possible consultation with practicing laboratories the draft was therefore circulated twice by EMQN to all laboratories participating in the EQA-scheme for CAH genotyping and was updated by that input. The present guidelines address quality requirements for diagnostic molecular genetic laboratories, as well as criteria for\u003cjats:italic\u003eCYP21A\u003c/jats:italic\u003e2 genotyping (including carrier-testing and prenatal diagnosis). A key aspect of that article is the use of appropriate methodologies (e.g., sequencing methods, MLPA (multiplex ligation dependent probe amplification), mutation specific assays) and respective limitations and analytical accuracy. Moreover, these guidelines focus on classification of variants, and the interpretation and standardization of the reporting of\u003cjats:italic\u003eCYP21A2\u003c/jats:italic\u003egenotyping results. In addition, the article provides a comprehensive list of common as well as so far unreported\u003cjats:italic\u003eCYP21A2\u003c/jats:italic\u003e-variants.\u003c/jats:p\u003e",
  "alternative-id": [
    "653"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "24 September 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "5 May 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "13 May 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "2 July 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-0928-6119",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Baumgartner-Parzer",
      "given": "Sabina",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Witsch-Baumgartner",
      "given": "Martina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hoeppner",
      "given": "Wolfgang",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        7,
        2
      ]
    ],
    "date-time": "2020-07-02T11:25:13Z",
    "timestamp": 1593689113000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ],
    "date-time": "2023-10-03T09:29:40Z",
    "timestamp": 1696325380000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        18
      ]
    ],
    "date-time": "2024-04-18T15:55:41Z",
    "timestamp": 1713455741002
  },
  "is-referenced-by-count": 49,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2020,
        7,
        2
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2020,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            7,
            2
          ]
        ],
        "date-time": "2020-07-02T00:00:00Z",
        "timestamp": 1593648000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            7,
            2
          ]
        ],
        "date-time": "2020-07-02T00:00:00Z",
        "timestamp": 1593648000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-020-0653-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-020-0653-5",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-020-0653-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1341-1367",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2020,
        7,
        2
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        7,
        2
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "PC White",
      "first-page": "245",
      "journal-title": "Endocr Rev",
      "key": "653_CR1",
      "unstructured": "White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21:245–91.",
      "volume": "21",
      "year": "2000"
    },
    {
      "DOI": "10.1056/NEJMra021561",
      "author": "PW Speiser",
      "doi-asserted-by": "crossref",
      "first-page": "776",
      "journal-title": "N Engl J Med",
      "key": "653_CR2",
      "unstructured": "Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med. 2003;349:776–88.",
      "volume": "349",
      "year": "2003"
    },
    {
      "DOI": "10.1210/jc.2009-2631",
      "author": "PW Speiser",
      "doi-asserted-by": "crossref",
      "first-page": "4133",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR3",
      "unstructured": "Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4133–60.",
      "volume": "95",
      "year": "2010"
    },
    {
      "DOI": "10.1530/EJE-16-0888",
      "author": "A Bachelot",
      "doi-asserted-by": "crossref",
      "first-page": "R167",
      "journal-title": "Eur J Endocrinol",
      "key": "653_CR4",
      "unstructured": "Bachelot A, Grouthier V, Courtillot C, Dulon J, Touraine P. 2017 Management of endocrine disease: congenital adrenal hyperplasia due to 21-hydroxylase deficiency: update on the management of adult patients and prenatal treatment. Eur J Endocrinol. 2017;176:R167–81.",
      "volume": "176",
      "year": "2017"
    },
    {
      "DOI": "10.1177/0004563214529748",
      "author": "JW Honour",
      "doi-asserted-by": "crossref",
      "first-page": "424",
      "journal-title": "Ann Clin Biochem",
      "key": "653_CR5",
      "unstructured": "Honour JW. 17-Hydroxyprogesterone in children, adolescents and adults. Ann Clin Biochem. 2014;51:424–40. (Pt 4)",
      "volume": "51",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.jsbmb.2016.06.015",
      "author": "AA Parsa",
      "doi-asserted-by": "crossref",
      "first-page": "2",
      "journal-title": "J Steroid Biochem Mol Biol",
      "key": "653_CR6",
      "unstructured": "Parsa AA, New MI. Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia. J Steroid Biochem Mol Biol. 2017;165:2–11.",
      "volume": "165",
      "year": "2017"
    },
    {
      "DOI": "10.1210/edrv-9-3-295",
      "author": "WL Miller",
      "doi-asserted-by": "crossref",
      "first-page": "295",
      "journal-title": "Endocr Rev",
      "key": "653_CR7",
      "unstructured": "Miller WL. Molecular biology of steroid hormone synthesis. Endocr Rev. 1988;9:295–318.",
      "volume": "9",
      "year": "1988"
    },
    {
      "DOI": "10.1016/S0889-8529(08)70017-3",
      "author": "BL Therell",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "journal-title": "Endocrinol Metab Clin North Am",
      "key": "653_CR8",
      "unstructured": "Therell BL. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am. 2001;30:15–30.",
      "volume": "30",
      "year": "2001"
    },
    {
      "author": "SD Grosse",
      "first-page": "284",
      "journal-title": "Horm Res",
      "key": "653_CR9",
      "unstructured": "Grosse SD, Van Vliet G. How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia? Horm Res. 2007;67:284–91.",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.beem.2015.04.002",
      "author": "EA Webb",
      "doi-asserted-by": "crossref",
      "first-page": "449",
      "journal-title": "Best Pract Res Clin Endocrinol Metab",
      "key": "653_CR10",
      "unstructured": "Webb EA, Krone N. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency. Best Pract Res Clin Endocrinol Metab. 2015;29:449–68.",
      "volume": "29",
      "year": "2015"
    },
    {
      "DOI": "10.1210/JC.2015-2093",
      "author": "H Falhammar",
      "doi-asserted-by": "crossref",
      "first-page": "3520",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR11",
      "unstructured": "Falhammar H, Frisen L, Linden Hirschberg A, Norrby C, Almqvist C, Nordenskjöld A, et al. Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedisch population-based national cohort study. J Clin Endocrinol Metab. 2015;100:3520–8.",
      "volume": "100",
      "year": "2015"
    },
    {
      "DOI": "10.1210/jc.2014-4033",
      "author": "MS Kim",
      "doi-asserted-by": "crossref",
      "first-page": "E1153",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR12",
      "unstructured": "Kim MS, Ryabets-Lienhard A, Dao-Tran A, Mittelman SD, Gilsanz V, Schrager SM, et al. Increased abdominal adiposity in adolescents and young adults with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2015;100:E1153–9.",
      "volume": "100",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s12020-015-0656-0",
      "author": "H Falhammar",
      "doi-asserted-by": "crossref",
      "first-page": "32",
      "journal-title": "Endocrine",
      "key": "653_CR13",
      "unstructured": "Falhammar H, Nordenström A. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine. 2015;50:32–50.",
      "volume": "50",
      "year": "2015"
    },
    {
      "DOI": "10.1210/jcem-55-5-817",
      "author": "B Kohn",
      "doi-asserted-by": "crossref",
      "first-page": "817",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR14",
      "unstructured": "Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D, et al. Late-onset steroid 21-hydroxlase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1982;55:817–27.",
      "volume": "55",
      "year": "1982"
    },
    {
      "DOI": "10.1186/s13633-015-0017-z",
      "author": "M Kanhere",
      "doi-asserted-by": "crossref",
      "first-page": "21",
      "journal-title": "Int J Pediatr Endocrinol",
      "key": "653_CR15",
      "unstructured": "Kanhere M, Fuqua J, Rink R, Houk C, Mauger D, Lee PA. Psychosexual development and quality of life outcomes in females with congenital adrenal hyperplasia. Int J Pediatr Endocrinol. 2015;2015:21.",
      "volume": "2015",
      "year": "2015"
    },
    {
      "DOI": "10.1159/000435855",
      "author": "M Yau",
      "doi-asserted-by": "crossref",
      "first-page": "165",
      "journal-title": "Horm Res Paediatr",
      "key": "653_CR16",
      "unstructured": "Yau M, Vogiatzi M, Lewkowitz-Shpuntoff A, Nimkarn S, Lin-Su K. Health-related quality of life in children with congenital adrenal hyperplasia. Horm Res Paediatr. 2015;84:165–71.",
      "volume": "84",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s12020-015-0731-6",
      "author": "H Falhammar",
      "doi-asserted-by": "crossref",
      "first-page": "306",
      "journal-title": "Endocrine",
      "key": "653_CR17",
      "unstructured": "Falhammar H, Wedell A, Nordenström A. Biochemical and genetic diagnosis of 21-hydroxylase deficiency. Endocrine. 2015;50:306–14.",
      "volume": "50",
      "year": "2015"
    },
    {
      "DOI": "10.1097/MED.0000000000000256",
      "author": "AF Turcu",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "journal-title": "Curr Opin Endocrinol Diabetes Obes",
      "key": "653_CR18",
      "unstructured": "Turcu AF, Auchus RJ. Novel treatment strategies in congenital adrenal hyperplasia. Curr Opin Endocrinol Diabetes Obes. 2016;23:225–32.",
      "volume": "23",
      "year": "2016"
    },
    {
      "DOI": "10.1542/peds.101.4.583",
      "author": "BL Therell Jr",
      "doi-asserted-by": "crossref",
      "first-page": "583",
      "journal-title": "Pediatrics",
      "key": "653_CR19",
      "unstructured": "Therell BL Jr, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, et al. Results of screening 1.9 million Texas newborns for 21-hydroxylase deficient congenital adrenal hyperplasia. Pediatrics. 1998;101:583–90.",
      "volume": "101",
      "year": "1998"
    },
    {
      "author": "PW Speiser",
      "first-page": "650",
      "journal-title": "Am J Hum Genet",
      "key": "653_CR20",
      "unstructured": "Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet. 1985;37:650–67.",
      "volume": "37",
      "year": "1985"
    },
    {
      "DOI": "10.1210/jc.2004-1728",
      "author": "SM Baumgartner- Parzer",
      "doi-asserted-by": "crossref",
      "first-page": "775",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR21",
      "unstructured": "Baumgartner- Parzer SM, Nowotny P, Waldhäusl W, Vierhapper H. Carrier frequency of Congenital Adrenal Hyperplasia (21-OH-deficiency) in a middle European population. J Clin Endocrinol Metab. 2004;90:775–8.",
      "volume": "90",
      "year": "2004"
    },
    {
      "DOI": "10.1210/jcem.85.3.6441",
      "author": "N Krone",
      "doi-asserted-by": "crossref",
      "first-page": "1059",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR22",
      "unstructured": "Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficieny? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab. 2000;85:1059–65.",
      "volume": "85",
      "year": "2000"
    },
    {
      "DOI": "10.1172/JCI115897",
      "author": "PW Speiser",
      "doi-asserted-by": "crossref",
      "first-page": "584",
      "journal-title": "J Clin Investig",
      "key": "653_CR23",
      "unstructured": "Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxlase deficiency. J Clin Investig. 1992;90:584–95.",
      "volume": "90",
      "year": "1992"
    },
    {
      "DOI": "10.1073/pnas.1300057110",
      "author": "MI New",
      "doi-asserted-by": "crossref",
      "first-page": "2611",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "653_CR24",
      "unstructured": "New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA. 2013;110:2611–6.",
      "volume": "110",
      "year": "2013"
    },
    {
      "DOI": "10.1210/jc.2006-2163",
      "author": "RS Araújo",
      "doi-asserted-by": "crossref",
      "first-page": "4028",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR25",
      "unstructured": "Araújo RS, Mendonca BB, Barbosa AS, Lin CJ, Marcondes AM, Billerbeck AEC, et al. Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2007;92/10:4028–34.",
      "volume": "92/10",
      "year": "2007"
    },
    {
      "author": "S Menabo",
      "first-page": "298",
      "journal-title": "J Endocrinol Invest",
      "key": "653_CR26",
      "unstructured": "Menabo S, Balsamo A, Baldazzi L, Barbaro M, Nicoletti A, Conti V, et al. A sequence variation in 3‵UTR of CYP21A2 gene correlates with a mild form of congenital adrenal hyperplasia. J Endocrinol Invest. 2012;35:298–305.",
      "volume": "35",
      "year": "2012"
    },
    {
      "DOI": "10.1093/hmg/5.12.2039",
      "author": "DJ Day",
      "doi-asserted-by": "crossref",
      "first-page": "2039",
      "journal-title": "Hum Mol Genet",
      "key": "653_CR27",
      "unstructured": "Day DJ, Speiser PW, Schultz E, Bettendorf M, Fitness J, Barany F, et al. Identification of non-amplifying CYP21-genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet. 1996;5:2039–48.",
      "volume": "5",
      "year": "1996"
    },
    {
      "DOI": "10.1002/pd.1584",
      "author": "B Ezquieta",
      "doi-asserted-by": "crossref",
      "first-page": "1172",
      "journal-title": "Prenat Diagn",
      "key": "653_CR28",
      "unstructured": "Ezquieta B, Beneyto M, Munoz-Pacheco R, Barrio R, Oyarzabal M, Lechuga JL, et al. Gene duplications in 21-hydroxylase deficiency: the importance of accurate molecular diagnosis in carrier detection and prenatal diagnosis. Prenat Diagn. 2006;26:1172–8.",
      "volume": "26",
      "year": "2006"
    },
    {
      "DOI": "10.1373/clinchem.2011.162230",
      "author": "P Concolino",
      "doi-asserted-by": "crossref",
      "first-page": "1079",
      "journal-title": "Clin Chem",
      "key": "653_CR29",
      "unstructured": "Concolino P, Mello E, Minucci A, Zuppi C, Capoluongo E. Multiplex ligation-dependent probe amplification analysis is useful for diagnosing congenital adrenal hyperplasia but requires a deep knowledge of CYP21A2 genetics. Clin Chem. 2011;57:1079–80.",
      "volume": "57",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ab.2011.02.016",
      "author": "LP Tsai",
      "doi-asserted-by": "crossref",
      "first-page": "133",
      "journal-title": "Anal Biochem",
      "key": "653_CR30",
      "unstructured": "Tsai LP, Cheng CF, Chuang SH, Lee HH. Analysis of the CYP21A1P pseudogene: indication of mutational diversity and CYP21A2-like and duplicated CYP21A2 genes. Anal Biochem. 2011;413:133–41.",
      "volume": "413",
      "year": "2011"
    },
    {
      "DOI": "10.1373/clinchem.2010.156893",
      "author": "C Cantürk",
      "doi-asserted-by": "crossref",
      "first-page": "511",
      "journal-title": "Clin Chem",
      "key": "653_CR31",
      "unstructured": "Cantürk C, Baade U, Salazar R, Storm N, Pörtner R, Höppner W. Sequence analysis of CYP21A1P in a German population to aid in the molecular biological diagnosis of congenital adrenal hyperplasia. Clin Chem. 2011;57/3:511–7.",
      "volume": "57/3",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ejhg.2010.101",
      "author": "CJ Mattocks",
      "doi-asserted-by": "crossref",
      "first-page": "1276",
      "journal-title": "Eur J Hum Genet",
      "key": "653_CR32",
      "unstructured": "Mattocks CJ, Morris MA, Matthijs G, Swinnen E, Corveleyn A, Dequeker E, et al. A standardized framework for the validation and verification of clinical molecular genetic tests. EuroGentest Valid Group. Eur J Hum Genet. 2010;18:1276–88.",
      "volume": "18",
      "year": "2010"
    },
    {
      "DOI": "10.1210/jcem-57-2-320",
      "author": "M New",
      "doi-asserted-by": "crossref",
      "first-page": "320",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR33",
      "unstructured": "New M, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab. 1983;57:320–6.",
      "volume": "57",
      "year": "1983"
    },
    {
      "DOI": "10.1111/cen.12935",
      "author": "U Ambroziak",
      "doi-asserted-by": "crossref",
      "first-page": "23",
      "journal-title": "Clin Endocrinol",
      "key": "653_CR34",
      "unstructured": "Ambroziak U, Kępczyńska-Nyk A, Kuryłowicz A, Małunowicz EM, Wójcicka A, Miśkiewicz P, et al. The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis. Clin Endocrinol. 2016;84:23–9.",
      "volume": "84",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.steroids.2006.01.015",
      "author": "M Rauh",
      "doi-asserted-by": "crossref",
      "first-page": "450",
      "journal-title": "Steroids",
      "key": "653_CR35",
      "unstructured": "Rauh M, Gröschl M, Rascher W, Dörr HG. Automated, fast and sensitive quantification of 17α-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction. Steroids. 2006;71:450–8.",
      "volume": "71",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.jchromb.2007.11.006",
      "author": "N Janzen",
      "doi-asserted-by": "crossref",
      "first-page": "117",
      "journal-title": "J Chromatogr B Anal Technol Biomed Life Sci",
      "key": "653_CR36",
      "unstructured": "Janzen N, Sander S, Terhardt M, Peter M, Sander J. Fast and direct quantification of adrenal steroids by tandem mass spectrometry in serum and dried blood spots. J Chromatogr B Anal Technol Biomed Life Sci. 2008;861:117–22.",
      "volume": "861",
      "year": "2008"
    },
    {
      "DOI": "10.1515/jpm-2013-0154",
      "author": "JY Seo",
      "doi-asserted-by": "crossref",
      "first-page": "121",
      "journal-title": "J Perinat Med",
      "key": "653_CR37",
      "unstructured": "Seo JY, Park HD, Kim JW, Oh HJ, Yang JS, Chang YS, et al. Steroid profilinig for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation. J Perinat Med. 2014;42/1:121–7.",
      "volume": "42/1",
      "year": "2014"
    },
    {
      "author": "J Fitness",
      "first-page": "960",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR38",
      "unstructured": "Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, et al. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1999;84:960–6.",
      "volume": "84",
      "year": "1999"
    },
    {
      "DOI": "10.1373/clinchem.2004.042416",
      "author": "S Kösel",
      "doi-asserted-by": "crossref",
      "first-page": "298",
      "journal-title": "Clin Chem",
      "key": "653_CR39",
      "unstructured": "Kösel S, Burggraf S, Fingerhut R, Dörr HG, Roscher AA, Olgemöller B. Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroylase deficiency. Clin Chem. 2005;51:298–304.",
      "volume": "51",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.cca.2012.09.013",
      "author": "S Nemeth",
      "doi-asserted-by": "crossref",
      "first-page": "211",
      "journal-title": "Clin Chim Acta",
      "key": "653_CR40",
      "unstructured": "Nemeth S, Riedl S, Kriegshäuser G, Baumgartner-Parzer S, Concolino P, Neocleous V, et al. Reverse-hybridization assay for rapid detection of common CYP21A2 mutations in dried blood spots from newborns with elevated 17-OH progesterone. Clin Chim Acta. 2012;414:211–4.",
      "volume": "414",
      "year": "2012"
    },
    {
      "DOI": "10.1111/j.1399-0004.2009.01274.x",
      "author": "EL Silveira",
      "doi-asserted-by": "crossref",
      "first-page": "503",
      "journal-title": "Clin Genet",
      "key": "653_CR41",
      "unstructured": "Silveira EL, Elnecave RH, dos Santos EP, Moura V, Pinto EM, von der Linden Nader I, et al. Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia. Clin Genet. 2009;76:503–10.",
      "volume": "76",
      "year": "2009"
    },
    {
      "DOI": "10.1371/journal.pone.0002138",
      "author": "S Parajes",
      "doi-asserted-by": "crossref",
      "first-page": "5.e2138",
      "journal-title": "Plos ONE",
      "key": "653_CR42",
      "unstructured": "Parajes S, Quinteiro C, Dominguez F, Loidi L. High frequency of copy number variations and sequence variants at CYP21A2 locus: implication for the genetic diagnosis of 21-hydroxylase deficiency. Plos ONE. 2008;3:5.e2138.",
      "volume": "3",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.fertnstert.2011.07.1103",
      "author": "E Trakakis",
      "doi-asserted-by": "crossref",
      "first-page": "1048",
      "journal-title": "Fertil Steril",
      "key": "653_CR43",
      "unstructured": "Trakakis E, Dracopoulou-Vabouli M, Dacou-Voutetakis C, Basios G, Chrelias C, Kassanos D. Infertility reversed by glucocorticoids and full-term pregnancy in a couple with previously undiagnosed nonclassic congenital adrenal hyperplasia. Fertil Steril. 2011;96/4:1048–50.",
      "volume": "96/4",
      "year": "2011"
    },
    {
      "DOI": "10.1046/j.1365-2265.2001.01359.x",
      "author": "N Krone",
      "doi-asserted-by": "crossref",
      "first-page": "523",
      "journal-title": "Clin Endocrinol",
      "key": "653_CR44",
      "unstructured": "Krone N, Wachter I, Stefanidou M, Roscher AA, Schwarz HP. Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol. 2001;55:523–9.",
      "volume": "55",
      "year": "2001"
    },
    {
      "DOI": "10.1210/jc.2009-1383",
      "author": "M Bidet",
      "doi-asserted-by": "crossref",
      "first-page": "1182",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR45",
      "unstructured": "Bidet M, Bellanne-Chantelot C, Galand-Portier M-B, Golmard J-L, Tardy V, Morel Y, et al. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2010;95/3:1182–90.",
      "volume": "95/3",
      "year": "2010"
    },
    {
      "author": "A Wedell",
      "first-page": "1145",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR46",
      "unstructured": "Wedell A, Thilén A, Ritzén EM, Stengler B, Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab. 1994;78:1145–52.",
      "volume": "78",
      "year": "1994"
    },
    {
      "DOI": "10.3109/09513590903215466",
      "author": "K Unluhizarci",
      "doi-asserted-by": "crossref",
      "first-page": "139",
      "journal-title": "Gynecol Endocrinol.",
      "key": "653_CR47",
      "unstructured": "Unluhizarci K, Kula M, Dundar M, Tanriverdi F, Israel S, Colak R, et al. The revalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism. Gynecol Endocrinol. 2010;26:139–43.",
      "volume": "26",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.fertnstert.2007.01.030",
      "author": "B Ezquieta",
      "doi-asserted-by": "crossref",
      "first-page": "1437.e5",
      "journal-title": "Fertil Steril",
      "key": "653_CR48",
      "unstructured": "Ezquieta B, Alonso M, Alvarez E, Arnao DR, Rodriguez A, Siguero PL. Should 21-hydroxylase deficiency genotyping be considered in assisted preproductive technology programs? Fertil Steril. 2007;88:1437.e5.",
      "volume": "88",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ejogrb.2014.09.014",
      "author": "S Baumgartner-Parzer",
      "doi-asserted-by": "crossref",
      "first-page": "258",
      "journal-title": "Eur J Obstet Gynecol Reprod Biol",
      "key": "653_CR49",
      "unstructured": "Baumgartner-Parzer S, Vytiska-Binsdorfer E, Kleinle S, Heinze G, Vierhapper H. Unexplained infertility: increased risk for 21-hydroxylase-deficiency in parents and offspring? Eur J Obstet Gynecol Reprod Biol. 2014;182:258–9.",
      "volume": "182",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ecl.2016.01.001",
      "author": "M Yau",
      "doi-asserted-by": "crossref",
      "first-page": "267",
      "journal-title": "Endocrinol Metab Clin North Am",
      "key": "653_CR50",
      "unstructured": "Yau M, Khattab A, New MI. Prenatal diagnosis of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am. 2016;45:267–81.",
      "volume": "45",
      "year": "2016"
    },
    {
      "author": "PW Speiser",
      "first-page": "90",
      "journal-title": "Horm Res",
      "key": "653_CR51",
      "unstructured": "Speiser PW. Prenatal and neonatal diagnosis and treatment of Congenital Adrenal Hyperplasia. Horm Res. 2007;68(Suppl 5):90–2.",
      "volume": "68",
      "year": "2007"
    },
    {
      "DOI": "10.1210/jc.2013-2895",
      "author": "V Tardy-Guidollet",
      "doi-asserted-by": "crossref",
      "first-page": "1180",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR52",
      "unstructured": "Tardy-Guidollet V, Menassa R, Costa J-M, David M, Bouvattier-Morel C, Baumann C, et al. New management strategy of pregnancies at risk of Congenital Adrenal Hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002–11). J Clin Endocrinol Metab. 2014;99:1180–8.",
      "volume": "99",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.beem.2015.01.005",
      "author": "WL Miller",
      "doi-asserted-by": "crossref",
      "first-page": "469",
      "journal-title": "Best Pract Res Clin Endocrinol Metab",
      "key": "653_CR53",
      "unstructured": "Miller WL. Fetal endocrine therapy for congenital adrenal hyperplasia should not be done. Best Pract Res Clin Endocrinol Metab. 2015;29:469–83.",
      "volume": "29",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.fertnstert.2018.11.041",
      "author": "JL Simpson",
      "doi-asserted-by": "crossref",
      "first-page": "21",
      "journal-title": "Fertil Steril",
      "key": "653_CR54",
      "unstructured": "Simpson JL, Rechitsky S. Prenatal genetic testing and treatment for congenital adrenal hyperplasia. Fertil Steril 2019;111:21–3.",
      "volume": "111",
      "year": "2019"
    },
    {
      "author": "JL Bartha",
      "first-page": "1135",
      "journal-title": "Obstet Gynecol",
      "key": "653_CR55",
      "unstructured": "Bartha JL, Finning K, Soothill PW. Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency. Obstet Gynecol. 2003;101:1135–6.",
      "volume": "101",
      "year": "2003"
    },
    {
      "author": "RJ Rijnders",
      "first-page": "374",
      "journal-title": "Obstet Gynecol",
      "key": "653_CR56",
      "unstructured": "Rijnders RJ, van der Schoot CE, Bossers B, de Vroede MA, Christiaens GC. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol. 2001;98:374–8.",
      "volume": "98",
      "year": "2001"
    },
    {
      "author": "V Tardy",
      "first-page": "348",
      "journal-title": "Horm Res",
      "key": "653_CR57",
      "unstructured": "Tardy V. Management of pregnancies at risk of 21-hydroxylase or 11-hydroxylase deficiency using fetal sex determination in maternal serum proposed in France since 2002: how to limit prenatal exposure to dexamethasone. Horm Res. 2009;70(Suppl 3):348.",
      "volume": "70",
      "year": "2009"
    },
    {
      "DOI": "10.1016/B978-0-12-814189-2.00009-8",
      "doi-asserted-by": "publisher",
      "key": "653_CR58",
      "unstructured": "Allen S, Young E, Gerrish A. Noninvasive prenatal diagnosis of monogenic disorders. In: Noninvasive Prenatal Testing (NIPT) applied genomics in prenatal screening and diagnosis. 2018; Editors: Lieve P-C and Klein H-G. https://doi.org/10.1016/B978-0-12-814189-2.00009-8."
    },
    {
      "DOI": "10.1210/jc.2014-1118",
      "author": "MI New",
      "doi-asserted-by": "crossref",
      "first-page": "E1022",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR59",
      "unstructured": "New MI, Tong YK, Yuen T, Jiang P, Pina C, Chan KCA, et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab. 2014;99:E1022–30.",
      "volume": "99",
      "year": "2014"
    },
    {
      "DOI": "10.1073/pnas.83.14.5111",
      "author": "PC White",
      "doi-asserted-by": "crossref",
      "first-page": "5111",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "653_CR60",
      "unstructured": "White PC, New MI, Dupont B. Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA. 1986;83:5111–5.",
      "volume": "83",
      "year": "1986"
    },
    {
      "DOI": "10.1073/pnas.83.9.2841",
      "author": "Y Higashi",
      "doi-asserted-by": "crossref",
      "first-page": "2841",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "653_CR61",
      "unstructured": "Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA. 1986;83:2841–5.",
      "volume": "83",
      "year": "1986"
    },
    {
      "author": "MS Pollack",
      "first-page": "540",
      "journal-title": "Am J Hum Genet",
      "key": "653_CR62",
      "unstructured": "Pollack MS, Levine LS, O’Neill GJ, Pang S, Lorenzen F, Kohn B, et al. HLA linkage and B14, DR1, BfS haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency. Am J Hum Genet. 1981;33:540–50.",
      "volume": "33",
      "year": "1981"
    },
    {
      "DOI": "10.1084/jem.191.12.2183",
      "author": "CA Blanchong",
      "doi-asserted-by": "crossref",
      "first-page": "2183",
      "journal-title": "J Exp Med",
      "key": "653_CR63",
      "unstructured": "Blanchong CA, Zhou B, Rupert KL, Chung EK, Jones KN, Sotos JF, et al. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med. 2000;191:2183–96.",
      "volume": "191",
      "year": "2000"
    },
    {
      "DOI": "10.1074/jbc.274.17.12147",
      "author": "Z Yang",
      "doi-asserted-by": "crossref",
      "first-page": "12147",
      "journal-title": "J Biol Chem",
      "key": "653_CR64",
      "unstructured": "Yang Z, Mendoza AR, Welch TR, Zipf WB, Yu CY. Modular variations of the human major histocompatibility complex class iii genes for serine/threonine kinase rp, complement component c4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX Module). A mechanism for gene deletions and disease associations. J Biol Chem. 1999;274:12147–56.",
      "volume": "274",
      "year": "1999"
    },
    {
      "DOI": "10.1073/pnas.85.20.7486",
      "author": "Y Higashi",
      "doi-asserted-by": "crossref",
      "first-page": "7486",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "653_CR65",
      "unstructured": "Higashi Y, Tanae A, Inoue H, Hiromasa T, Fujii-Kuriyama Y. Aberrant splicing and missense mutations cause steroid 21-hydroxylase (P450 (C21)) deficiency in humans: possible gene conversion products. Proc Natl Acad Sci USA. 1988;85:7486–90.",
      "volume": "85",
      "year": "1988"
    },
    {
      "DOI": "10.1073/pnas.87.6.2107",
      "author": "P Sinnott",
      "doi-asserted-by": "crossref",
      "first-page": "2107",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "653_CR66",
      "unstructured": "Sinnott P, Collier S, Costigan C, Dyer PA, Harris R, Strachan T. Genesis by meiotic unequal crossover of a de novo deletion that contributes to steroid hydroxylase deficiency. Proc Natl Acad Sci USA. 1990;87:2107–11.",
      "volume": "87",
      "year": "1990"
    },
    {
      "DOI": "10.1002/humu.23351",
      "author": "L Simonetti",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "journal-title": "Hum Mutat",
      "key": "653_CR67",
      "unstructured": "Simonetti L, Bruque CD, Fernández CS, Benavides-Mori B, Delea M, Kolomenski JE, et al. CYP21A2 mutation update: comprehensive analysis of databases and published genetic variants. Hum Mutat. 2018;39:5–22.",
      "volume": "39",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s40291-018-0319-y",
      "author": "P Concolino",
      "doi-asserted-by": "crossref",
      "first-page": "261",
      "journal-title": "Mol Diagn Ther",
      "key": "653_CR68",
      "unstructured": "Concolino P, Costella A. Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency: a comprehensive focus on 233 pathogenic variants of CYP21A2 gene. Mol Diagn Ther. 2018;22:261–80.",
      "volume": "22",
      "year": "2018"
    },
    {
      "DOI": "10.1210/jcem.86.10.7898",
      "author": "SM Baumgartner- Parzer",
      "doi-asserted-by": "crossref",
      "first-page": "4771",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR69",
      "unstructured": "Baumgartner- Parzer SM, Schulze E, Waldhäusl W, Pauschenwein S, Rondot S, Nowotny P, et al. Mutational spectrum of the steroid 21- hydroxylase gene in Austria: Identification of a novel missense mutation. J Clin Endocrinol Metab. 2001;86:4771–5.",
      "volume": "86",
      "year": "2001"
    },
    {
      "DOI": "10.1210/jc.2002-021589",
      "author": "SM Baumgartner-Parzer",
      "doi-asserted-by": "crossref",
      "first-page": "2794",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR70",
      "unstructured": "Baumgartner-Parzer SM, Nowotny P, Waldhäusl W, Vierhapper H. A rare duplicated 21-OH haplotype and a de novo mutation—a family analysis. J Clin Endocrinol Metab. 2003;88:2794–6.",
      "volume": "88",
      "year": "2003"
    },
    {
      "author": "RC Wilson",
      "first-page": "2322",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR71",
      "unstructured": "Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab. 1995;80:2322–9.",
      "volume": "80",
      "year": "1995"
    },
    {
      "DOI": "10.1530/EJE-11-0019",
      "author": "R Nandagopal",
      "doi-asserted-by": "crossref",
      "first-page": "977",
      "journal-title": "Eur J Endocrinol",
      "key": "653_CR72",
      "unstructured": "Nandagopal R, Sinaii N, Avila NA, Van Ryzin C, Chen W, Finkielstain GP, et al. Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families. Eur J Endocrinol. 2011;164:977–84.",
      "volume": "164",
      "year": "2011"
    },
    {
      "author": "E Grodnitskaya",
      "first-page": "1",
      "journal-title": "Hum Fertil",
      "key": "653_CR73",
      "unstructured": "Grodnitskaya E, Kurtser M. The prevalence of non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Russian women with hyperandrogenism. Hum Fertil. 2017;3:1–6.",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.3109/09513590903511505",
      "author": "F Paris",
      "doi-asserted-by": "crossref",
      "first-page": "319",
      "journal-title": "Gynecol Endocrinol",
      "key": "653_CR74",
      "unstructured": "Paris F, Tardy V, Chalancon A, Picot MC, Morel Y, Sultan C. Premature pubarche in Mediterranean girls: high prevalence of heterozygous CYP21 mutation carriers. Gynecol Endocrinol. 2010;26:319–24.",
      "volume": "26",
      "year": "2010"
    },
    {
      "DOI": "10.1530/EJE-14-1084",
      "author": "AE Kulle",
      "doi-asserted-by": "crossref",
      "first-page": "517",
      "journal-title": "Eur J Endocrinol",
      "key": "653_CR75",
      "unstructured": "Kulle AE, Riepe FG, Hedderich J, Sippell WG, Schmitz J, Niermeyer L, et al. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers. Eur J Endocrinol. 2015;173:517–24.",
      "volume": "173",
      "year": "2015"
    },
    {
      "DOI": "10.1530/EJE-11-0119",
      "author": "L Ghizzoni",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "journal-title": "Eur J Endocrinol",
      "key": "653_CR76",
      "unstructured": "Ghizzoni L, Cappa M, Vottero A, Ubertini G, Carta D, Di Iorgi N, et al. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche. Eur J Endocrinol. 2011;165:307–14.",
      "volume": "165",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s40618-014-0223-1",
      "author": "N Skordis",
      "doi-asserted-by": "crossref",
      "first-page": "535",
      "journal-title": "J Endocrinol Investig",
      "key": "653_CR77",
      "unstructured": "Skordis N, Shammas C, Phedonos AA, Kyriakou A, Toumba M, Neocleous V, et al. Genetic defects of the CYP21A2 gene in girls with premature adrenarche. J Endocrinol Investig. 2015;38:535–9.",
      "volume": "38",
      "year": "2015"
    },
    {
      "DOI": "10.1210/jcem.85.12.7018",
      "author": "D LʼÀllemand",
      "doi-asserted-by": "crossref",
      "first-page": "4562",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR78",
      "unstructured": "LʼÀllemand D, Tardy V, Grüters A, Schnabel D, Krude H, Morel Y. How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2000;85:4562–7.",
      "volume": "85",
      "year": "2000"
    },
    {
      "DOI": "10.1111/j.1365-2265.2008.03356.x",
      "author": "HJ Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "201",
      "journal-title": "Clin Endocrinol",
      "key": "653_CR79",
      "unstructured": "Zhang HJ, Yang J, Zhang M, Zhang W, Liut J, Wang W, et al. Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxlase deficiency. Clin Endocrinol. 2009;70:201–7.",
      "volume": "70",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1365-2265.2005.02184.x",
      "author": "RS Araújo",
      "doi-asserted-by": "crossref",
      "first-page": "132",
      "journal-title": "Clin Endocrinol",
      "key": "653_CR80",
      "unstructured": "Araújo RS, Billerbeck AEC, Madureira G, Mendonca BB, Bachega TASS. Substitutions in the CYP21A2 promoter explain the simple virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation. Clin Endocrinol. 2005;62:132–6.",
      "volume": "62",
      "year": "2005"
    },
    {
      "author": "SF Chang",
      "first-page": "1330",
      "journal-title": "Mol Endocrinol",
      "key": "653_CR81",
      "unstructured": "Chang SF, Chung B. Difference in transcriptional activity of two homologous CYP21A genes. Mol Endocrinol. 1995;9/10:1330–6.",
      "volume": "9/10",
      "year": "1995"
    },
    {
      "DOI": "10.1093/nar/26.8.1959",
      "author": "KK Chin",
      "doi-asserted-by": "crossref",
      "first-page": "1959",
      "journal-title": "Nucl Acids Res",
      "key": "653_CR82",
      "unstructured": "Chin KK, Chang SF. The -104G nucleotide of the human CYP21 gene is important for CYP21 transcription activity and protein interaction. Nucl Acids Res. 1998;26/8:1959–64.",
      "volume": "26/8",
      "year": "1998"
    },
    {
      "DOI": "10.1186/1471-2350-10-72",
      "author": "P Concolino",
      "doi-asserted-by": "crossref",
      "first-page": "72",
      "journal-title": "BMC Med Genet",
      "key": "653_CR83",
      "unstructured": "Concolino P, Mello E, Minucci A, Giardina E, Zuppi C, Toscano V, et al. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form. BMC Med Genet. 2009;10:72–7.",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1073/pnas.92.23.10796",
      "author": "MT Tusié-Luna",
      "doi-asserted-by": "crossref",
      "first-page": "10796",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "653_CR84",
      "unstructured": "Tusié-Luna MT, White PC. Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci USA. 1995;92:10796–800.",
      "volume": "92",
      "year": "1995"
    },
    {
      "DOI": "10.1007/s10038-003-0115-2",
      "author": "HH Lee",
      "doi-asserted-by": "crossref",
      "first-page": "65",
      "journal-title": "J Hum Genet",
      "key": "653_CR85",
      "unstructured": "Lee HH. The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency. J Hum Genet. 2004;49:65–72.",
      "volume": "49",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmg.40.5.e53",
      "author": "PF Koppens",
      "doi-asserted-by": "crossref",
      "first-page": "e53",
      "journal-title": "J Med Genet",
      "key": "653_CR86",
      "unstructured": "Koppens PF, Smeets JH, deWijs IJ, Degenhart JH. Mapping of a de novo uneual crossover causing a deletion of the steroid 21-hydroxylase (CYP1A2) gene and a non-functional hybrid tenascin-X (TNXB) gene. J Med Genet. 2003;40:e53.",
      "volume": "40",
      "year": "2003"
    },
    {
      "DOI": "10.1007/978-1-4684-5958-6_1",
      "doi-asserted-by": "crossref",
      "key": "653_CR87",
      "unstructured": "Morel Y, Murena M, Nicolino M, Forest MG. Molecular genetics of the congenital adrenal hyperplasia due to 21-hydroxylase deficiency. In: Saez JM, Brownie AC, Capponi A, Chambaz EM, editors. Cellular and molecular biology of the adrenal cortex. 1992;222:123–36."
    },
    {
      "DOI": "10.1007/BF00218263",
      "author": "A Wedell",
      "doi-asserted-by": "crossref",
      "first-page": "236",
      "journal-title": "Hum Genet",
      "key": "653_CR88",
      "unstructured": "Wedell A, Luthman H. Steroid 21-hydroxylase (450c21): a new allele and spread of mutations through the pseudogene. Hum Genet. 1993;91:236–40.",
      "volume": "91",
      "year": "1993"
    },
    {
      "DOI": "10.1016/j.ymgmr.2014.07.002",
      "author": "CN Greene",
      "doi-asserted-by": "crossref",
      "first-page": "312",
      "journal-title": "Mol Genet Metab Rep",
      "key": "653_CR89",
      "unstructured": "Greene CN, Cordovado SK, Turner DP, Keong LM, Shulman D, Mueller PW. Novel method to characterize CYP21A2 in Florida patients with congenital adrenal hyperplasia and commercially available cell lines. Mol Genet Metab Rep. 2014;1:312–23.",
      "volume": "1",
      "year": "2014"
    },
    {
      "DOI": "10.3109/07435809809032662",
      "author": "E Schulze",
      "doi-asserted-by": "crossref",
      "first-page": "637",
      "journal-title": "Endocr Res",
      "key": "653_CR90",
      "unstructured": "Schulze E, Bettendorf M, Maser-Gluth C, Decker M, Schwabe U. Allele-dropout using pcr-based diagnosis for the splicing mutation in intron-2 of the CYP21B-gene: successful amplification with a TAQ/PWO-polymerase mixture. Endocr Res. 1998;24:637–41.",
      "volume": "24",
      "year": "1998"
    },
    {
      "DOI": "10.1093/nar/gnf056",
      "author": "JP Schouten",
      "doi-asserted-by": "crossref",
      "first-page": "e57",
      "journal-title": "Nucleic Acids Res",
      "key": "653_CR91",
      "unstructured": "Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplificiation. Nucleic Acids Res. 2002;30:e57.",
      "volume": "30",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.cca.2009.01.008",
      "author": "P Concolino",
      "doi-asserted-by": "crossref",
      "first-page": "164",
      "journal-title": "Clin Chim Acta",
      "key": "653_CR92",
      "unstructured": "Concolino P, Mello E, Toscano V, Ameglio F, Zuppi C, Capoluongo E. Multiplex ligation-dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions/duplications in Congenital Adrenal Hyperplasia: first technical report. Clin Chim Acta. 2009;402:164–70.",
      "volume": "402",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s11154-007-9053-1",
      "author": "FG Riepe",
      "doi-asserted-by": "crossref",
      "first-page": "349",
      "journal-title": "Rev Endocr Metab Disord",
      "key": "653_CR93",
      "unstructured": "Riepe FG, Sippell W. Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiciency. Rev Endocr Metab Disord. 2007;8:349–63.",
      "volume": "8",
      "year": "2007"
    },
    {
      "DOI": "10.1007/BF02272841",
      "author": "A Wedell",
      "doi-asserted-by": "crossref",
      "first-page": "50",
      "journal-title": "Hum Genet",
      "key": "653_CR94",
      "unstructured": "Wedell A, Stengler B, Luthman H. Characterization of mutations on the rare duplicated C4/CYP21 haplotype in steroid 21-hydroxylase deficiency. Hum Genet. 1994;94:50–4.",
      "volume": "94",
      "year": "1994"
    },
    {
      "DOI": "10.1210/jc.2009-0487",
      "author": "S Kleinle",
      "doi-asserted-by": "crossref",
      "first-page": "3954",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR95",
      "unstructured": "Kleinle S, Lang R, Fischer GF, Vierhapper H, Waldhauser F, Födinger M, et al. Duplications of the functional CYP21A2 gene are primarely restricted to Q318X alleles: evidence for a founder effect. J Clin Endocrinol Metab. 2009;94:3954–8.",
      "volume": "94",
      "year": "2009"
    },
    {
      "DOI": "10.1111/nyas.13370",
      "author": "S Gurgov",
      "doi-asserted-by": "crossref",
      "first-page": "56",
      "journal-title": "Ann NY Acad Sci",
      "key": "653_CR96",
      "unstructured": "Gurgov S, Bernabé KJ, Stites J, Cunniff CM, Lin-Su K, Felsen D, et al. Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype. Ann NY Acad Sci. 2017;1402:56–63.",
      "volume": "1402",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s13073-016-0391-z",
      "author": "RY Patel",
      "doi-asserted-by": "crossref",
      "journal-title": "Genome Med",
      "key": "653_CR97",
      "unstructured": "Patel RY, Shah N, Jackson AR, Ghosh R, Pawliczek P, Paithankar S, et al. ClinGen Pathogenicity Calculator: a configurable system for assessing pathogenicity of genetic variants. Genome Med. 2017;9:3.",
      "volume": "9",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "crossref",
      "first-page": "405",
      "journal-title": "Genet Med.",
      "key": "653_CR98",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1097/GIM.0b013e31816b5cae",
      "author": "CS Richards",
      "doi-asserted-by": "crossref",
      "first-page": "294",
      "journal-title": "Genet Med",
      "key": "653_CR99",
      "unstructured": "Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, et al. ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007. Genet Med. 2008;10:294–300.",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1002/humu.20880",
      "author": "SE Plon",
      "doi-asserted-by": "crossref",
      "first-page": "1282",
      "journal-title": "Hum Mutat.",
      "key": "653_CR100",
      "unstructured": "Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2008;29:1282–91.",
      "volume": "29",
      "year": "2008"
    },
    {
      "author": "VT Tardy",
      "first-page": "292",
      "journal-title": "Hum Genet.",
      "key": "653_CR101",
      "unstructured": "Tardy VT, Morel Y. Gene symbol: CYP21A2. Hum Genet. 2007;121/2:292–3.",
      "volume": "121/2",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.gene.2012.10.059",
      "author": "B Toraman",
      "doi-asserted-by": "crossref",
      "first-page": "202",
      "journal-title": "Gene.",
      "key": "653_CR102",
      "unstructured": "Toraman B, Ökten A, Kalay E, Karagüzel G, Dinçer T, Açıkgöz EG, et al. Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation. Gene. 2013;513/1:202–8.",
      "volume": "513/1",
      "year": "2013"
    },
    {
      "DOI": "10.1111/ahg.12083",
      "author": "D Kirac",
      "doi-asserted-by": "crossref",
      "first-page": "399",
      "journal-title": "Ann Hum Genet",
      "key": "653_CR103",
      "unstructured": "Kirac D, Guney AI, Akcay T, Guran T, Ulucan K, Turan S, et al. The frequency and the effects of 21-hydroxylase gene defects in congenital adrenal hyperplasia patients. Ann Hum Genet. 2014;78/6:399–409.",
      "volume": "78/6",
      "year": "2014"
    },
    {
      "author": "T Usui",
      "first-page": "126",
      "journal-title": "Horm Res.",
      "key": "653_CR104",
      "unstructured": "Usui T, Nishisho K, Kaji M, Ikuno N, Yorifuji T, Yasuda T, et al. Three novel mutations in Japanese patients with 21-hydroxylase deficiency. Horm Res. 2004;61/3:126–32.",
      "volume": "61/3",
      "year": "2004"
    },
    {
      "DOI": "10.1111/j.1365-2265.2007.02886.x",
      "author": "A Baradaran-Heravi",
      "doi-asserted-by": "crossref",
      "first-page": "335",
      "journal-title": "Clin Endocrinol (Oxf)",
      "key": "653_CR105",
      "unstructured": "Baradaran-Heravi A, Vakili R, Robins T, Carlsson J, Ghaemi N, Aʼrabi A, et al. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran. Clin Endocrinol (Oxf). 2007;67/3:335–41.",
      "volume": "67/3",
      "year": "2007"
    },
    {
      "DOI": "10.1002/j.1460-2075.1987.tb02414.x",
      "author": "NR Rodrigues",
      "doi-asserted-by": "crossref",
      "first-page": "1653",
      "journal-title": "EMBO J.",
      "key": "653_CR106",
      "unstructured": "Rodrigues NR, Dunham I, Yu CY, Carroll MC, Porter RR, Campbell RD. Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J. 1987;6/6:1653–61.",
      "volume": "6/6",
      "year": "1987"
    },
    {
      "DOI": "10.1155/2016/4209670",
      "author": "D De Paula Michelatto",
      "doi-asserted-by": "crossref",
      "first-page": "4209670",
      "journal-title": "Int J Endocrinol",
      "key": "653_CR107",
      "unstructured": "De Paula Michelatto D, Karlsson L, Lusa AL, Silva CD, Östberg LJ, Persson B, et al. Functional and Structural Consequences of Nine CYP21A2 Mutations Ranging from Very Mild to Severe Effects. Int J Endocrinol. 2016;2016:4209670.",
      "volume": "2016",
      "year": "2016"
    },
    {
      "DOI": "10.1530/eje.0.1490137",
      "author": "V Dolzan",
      "doi-asserted-by": "crossref",
      "first-page": "137",
      "journal-title": "Europ J Endocrinol",
      "key": "653_CR108",
      "unstructured": "Dolzan V, Stopar-Obreza W, Zerjav-Tansek M, Breskvar K, Krzisnik C, Battelino T. Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease. Europ J Endocrinol. 2003;149/2:137–44.",
      "volume": "149/2",
      "year": "2003"
    },
    {
      "DOI": "10.1210/jc.2003-031056",
      "author": "M Kharrat",
      "doi-asserted-by": "crossref",
      "first-page": "368",
      "journal-title": "Clin Endocrinol Metab.",
      "key": "653_CR109",
      "unstructured": "Kharrat M, Tardy V, MʼRad R, Maazoul F, Jemaa LB, Refaï M, et al. Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. Clin Endocrinol Metab. 2004;89/1:368–74.",
      "volume": "89/1",
      "year": "2004"
    },
    {
      "DOI": "10.1210/jc.2008-1582",
      "author": "M Bidet",
      "doi-asserted-by": "crossref",
      "first-page": "1570",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR110",
      "unstructured": "Bidet M, Bellanné-Chantelot C, Galand-Portier MB, Tardy V, Bilaud L, Laborde K, et al. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab. 2009;94/5:1570–8.",
      "volume": "94/5",
      "year": "2009"
    },
    {
      "author": "B Ezquieta",
      "first-page": "135",
      "journal-title": "Horm Res.",
      "key": "653_CR111",
      "unstructured": "Ezquieta B, Oyarzábal M, Jariego CM, Varela JM, Chueca M. A novel frameshift mutation in the first exon of the 21-OH gene found in homozygosity in an apparently nonconsanguineous family. Horm Res. 1999;51/3:135–41.",
      "volume": "51/3",
      "year": "1999"
    },
    {
      "DOI": "10.1007/s004390050186",
      "author": "S Lajic",
      "doi-asserted-by": "crossref",
      "first-page": "182",
      "journal-title": "Hum Genet.",
      "key": "653_CR112",
      "unstructured": "Lajic S, Wedell A. An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia. Hum Genet. 1996;98/2:182–4.",
      "volume": "98/2",
      "year": "1996"
    },
    {
      "DOI": "10.1007/BF03350823",
      "author": "L Di Pasquale",
      "doi-asserted-by": "crossref",
      "first-page": "806",
      "journal-title": "J Endocrinol Invest",
      "key": "653_CR113",
      "unstructured": "Di Pasquale L, Indovina S, Wasniewska M, Mirabelli S, Porcelli P, Rulli I, et al. Novel nonsense mutation (W22X) in CYP21A2 gene causing salt-wasting congenital adrenal hyperplasia in a compound heterozygous girl. J Endocrinol Invest. 2007;30/9:806–7.",
      "volume": "30/9",
      "year": "2007"
    },
    {
      "DOI": "10.1210/jcem.86.12.8113",
      "author": "IF Lau",
      "doi-asserted-by": "crossref",
      "first-page": "5877",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR114",
      "unstructured": "Lau IF, Soardi FC, Lemos-Marini SH, Guerra G Jr, Baptista MT, De Mello MP. H28+C insertion in the CYP21 gene: a novel frameshift mutation in a Brazilian patient with the classical form of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2001;86/12:5877–80.",
      "volume": "86/12",
      "year": "2001"
    },
    {
      "DOI": "10.1006/bbrc.1999.0482",
      "author": "S Lajic",
      "doi-asserted-by": "crossref",
      "first-page": "384",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "653_CR115",
      "unstructured": "Lajic S, Nikoshkov A, Holst M, Wedell A. Effects of missense mutations and deletions on membrane anchoring and enzyme function of human steroid 21-hydroxylase (P450c21). Biochem Biophys Res Commun. 1999;257/2:384–90.",
      "volume": "257/2",
      "year": "1999"
    },
    {
      "DOI": "10.1210/mend-5-5-685",
      "author": "MT Tusie-Luna",
      "doi-asserted-by": "crossref",
      "first-page": "685",
      "journal-title": "Mol Endocrinol.",
      "key": "653_CR116",
      "unstructured": "Tusie-Luna MT, Speiser PW, Dumic M, New MI, White PC. A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol Endocrinol. 1991;5/5:685–92.",
      "volume": "5/5",
      "year": "1991"
    },
    {
      "author": "Z Vrzalová",
      "first-page": "595",
      "journal-title": "Int J Mol Med",
      "key": "653_CR117",
      "unstructured": "Vrzalová Z, Hrubá Z, Stʼahlová Hrabincová E, Pouchlá S, Votava F, Kolousková S, et al. Identification of CYP21A2 mutant alleles in Czech patients with 21-hydroxylase deficiency. Int J Mol Med. 2010;26/4:595–603.",
      "volume": "26/4",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s40618-015-0366-8",
      "author": "I Milacic",
      "doi-asserted-by": "crossref",
      "first-page": "1199",
      "journal-title": "J Endocrinol Invest",
      "key": "653_CR118",
      "unstructured": "Milacic I, Barac M, Milenkovic T, Ugrin M, Klaassen K, Skakic A, et al. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations. J Endocrinol Invest. 2015;38/11:1199–210.",
      "volume": "38/11",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.steroids.2016.01.007",
      "author": "R Wang",
      "doi-asserted-by": "crossref",
      "first-page": "47",
      "journal-title": "Steroids.",
      "key": "653_CR119",
      "unstructured": "Wang R, Yu Y, Ye J, Han L, Qiu W, Zhang H, et al. 21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype-phenotype correlation and identification of nine novel mutations. Steroids. 2016;108:47–55.",
      "volume": "108",
      "year": "2016"
    },
    {
      "DOI": "10.1210/jc.2010-0319",
      "author": "GP Finkielstain",
      "doi-asserted-by": "crossref",
      "first-page": "E161",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR120",
      "unstructured": "Finkielstain GP, Chen W, Mehta SP, Fujimura FK, Hanna RM, Van Ryzin C, et al. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2011;96/1:E161–72.",
      "volume": "96/1",
      "year": "2011"
    },
    {
      "DOI": "10.1111/cen.12526",
      "author": "M Barbaro",
      "doi-asserted-by": "crossref",
      "first-page": "37",
      "journal-title": "Clin Endocrinol (Oxf)",
      "key": "653_CR121",
      "unstructured": "Barbaro M, Soardi FC, Östberg LJ, Persson B, de Mello MP, Wedell A, et al. In vitro functional studies of rare CYP21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia. Clin Endocrinol (Oxf). 2015;82/1:37–44.",
      "volume": "82/1",
      "year": "2015"
    },
    {
      "author": "V Tardy",
      "first-page": "363",
      "journal-title": "Hum Genet.",
      "key": "653_CR122",
      "unstructured": "Tardy V. Gene symbol: CYP21A2. Disease: steroid 21-hydroxylase deficiency. Hum Genet. 2006;119/3:363.",
      "volume": "119/3",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1365-2265.2011.04123.x",
      "author": "R Marino",
      "doi-asserted-by": "crossref",
      "first-page": "427",
      "journal-title": "Clin Endocrinol (Oxf)",
      "key": "653_CR123",
      "unstructured": "Marino R, Ramirez P, Galeano J, Perez Garrido N, Rocco C, Ciaccio M, et al. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf). 2011;75/4:427–35.",
      "volume": "75/4",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ymgme.2004.02.006",
      "author": "X Zeng",
      "doi-asserted-by": "crossref",
      "first-page": "38",
      "journal-title": "Mol Genet Metab",
      "key": "653_CR124",
      "unstructured": "Zeng X, Witchel SF, Dobrowolski SF, Moulder PV, Jarvik JW, Telmer CA. Detection and assignment of CYP21 mutations using peptide mass signature genotyping. Mol Genet Metab. 2004;82/1:38–47.",
      "volume": "82/1",
      "year": "2004"
    },
    {
      "DOI": "10.1530/EC-14-0032",
      "author": "I Brønstad",
      "doi-asserted-by": "crossref",
      "first-page": "67",
      "journal-title": "Endocr Connect",
      "key": "653_CR125",
      "unstructured": "Brønstad I, Breivik L, Methlie P, Wolff AS, Bratland E, Nermoen I, et al. Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia. Endocr Connect. 2014;3/2:67–74.",
      "volume": "3/2",
      "year": "2014"
    },
    {
      "DOI": "10.1111/j.1365-2265.2006.02465.x",
      "author": "L Loidi",
      "doi-asserted-by": "crossref",
      "first-page": "330",
      "journal-title": "Clin Endocrinol (Oxf)",
      "key": "653_CR126",
      "unstructured": "Loidi L, Quinteiro C, Parajes S, Barreiro J, Lestón DG, Cabezas-Agrícola JM, et al. High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect. Clin Endocrinol (Oxf). 2006;64/3:330–6.",
      "volume": "64/3",
      "year": "2006"
    },
    {
      "author": "VT Tardy",
      "first-page": "293",
      "journal-title": "Hum Genet.",
      "key": "653_CR127",
      "unstructured": "Tardy VT, Morel Y. Gene symbol: CYP21A2. Hum Genet. 2007;121/2:293–4.",
      "volume": "121/2",
      "year": "2007"
    },
    {
      "author": "P Concolino",
      "first-page": "824",
      "journal-title": "Clin Chem Lab Med",
      "key": "653_CR128",
      "unstructured": "Concolino P, Minucci A, Mello E, Zuppi C, Capoluongo E. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency. Clin Chem Lab Med. 2009;47/7:824–5.",
      "volume": "47/7",
      "year": "2009"
    },
    {
      "DOI": "10.1210/jc.2007-2594",
      "author": "FC Soardi",
      "doi-asserted-by": "crossref",
      "first-page": "2416",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR129",
      "unstructured": "Soardi FC, Barbaro M, Lau IF, Lemos-Marini SH, Baptista MT, Guerra-Junior G, et al. Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients. J Clin Endocrinol Metab. 2008;93/6:2416–20.",
      "volume": "93/6",
      "year": "2008"
    },
    {
      "DOI": "10.1210/jc.2007-2701",
      "author": "R Menassa",
      "doi-asserted-by": "crossref",
      "first-page": "1901",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR130",
      "unstructured": "Menassa R, Tardy V, Despert F, Bouvattier-Morel C, Brossier JP, Cartigny M, et al. p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2008;93/5:1901–8.",
      "volume": "93/5",
      "year": "2008"
    },
    {
      "DOI": "10.1002/(SICI)1098-1004(1999)13:6\u003c482::AID-HUMU8\u003e3.0.CO;2-0",
      "author": "G Ohlsson",
      "doi-asserted-by": "crossref",
      "first-page": "482",
      "journal-title": "Hum Mutat.",
      "key": "653_CR131",
      "unstructured": "Ohlsson G, Müller J, Skakkebaek NE, Schwartz M. Steroid 21-hydroxylase deficiency: mutational spectrum in Denmark, three novel mutations, and in vitro expression analysis. Hum Mutat. 1999;13/6:482–6.",
      "volume": "13/6",
      "year": "1999"
    },
    {
      "DOI": "10.1186/1423-0127-16-3",
      "author": "S Dubey",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "journal-title": "J Biomed Sci",
      "key": "653_CR132",
      "unstructured": "Dubey S, Idicula-Thomas S, Anwaruddin M, Saravanan C, Varma RR, Maitra A. A novel 9-bp insertion detected in steroid 21-hydroxylase gene (CYP21A2): prediction of its structural and functional implications by computational methods. J Biomed Sci. 2009;16:3.",
      "volume": "16",
      "year": "2009"
    },
    {
      "DOI": "10.1006/bbrc.1999.1271",
      "author": "BS Nunez",
      "doi-asserted-by": "crossref",
      "first-page": "635",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "653_CR133",
      "unstructured": "Nunez BS, Lobato MN, White PC, Meseguer A. Functional analysis of four CYP21 mutations from spanish patients with congenital adrenal hyperplasia. Biochem Biophys Res Commun. 1999;262/3:635–7.",
      "volume": "262/3",
      "year": "1999"
    },
    {
      "DOI": "10.1210/jc.2004-0813",
      "author": "N Krone",
      "doi-asserted-by": "crossref",
      "first-page": "445",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR134",
      "unstructured": "Krone N, Riepe FG, Grötzinger J, Partsch CJ, Sippell WG. Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2005;90/1:445–54.",
      "volume": "90/1",
      "year": "2005"
    },
    {
      "author": "P Balraj",
      "first-page": "366",
      "journal-title": "J Endocrinol Invest",
      "key": "653_CR135",
      "unstructured": "Balraj P, Lim PG, Sidek H, Wu LL, Khoo AS. Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia. J Endocrinol Invest. 2013;36/6:366–74.",
      "volume": "36/6",
      "year": "2013"
    },
    {
      "DOI": "10.1677/joe.0.1710397",
      "author": "HH Lee",
      "doi-asserted-by": "crossref",
      "first-page": "397",
      "issue": "Dec",
      "journal-title": "J Endocrinol.",
      "key": "653_CR136",
      "unstructured": "Lee HH, Chang SF. Multiple transcripts of the CYP21 gene are generated by the mutation of the splicing donor site in intron 2 from GT to AT in 21-hydroxylase deficiency. J Endocrinol. 2001;171(Dec):397–402.",
      "volume": "171",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.ymgme.2005.11.015",
      "author": "A Friães",
      "doi-asserted-by": "crossref",
      "first-page": "58",
      "journal-title": "Mol Genet Metab",
      "key": "653_CR137",
      "unstructured": "Friães A, Rêgo AT, Aragüés JM, Moura LF, Mirante A, Mascarenhas MR, et al. CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions. Mol Genet Metab. 2006;88/1:58–65.",
      "volume": "88/1",
      "year": "2006"
    },
    {
      "author": "PM Rubtsov",
      "first-page": "815",
      "journal-title": "Bioorg Khim.",
      "key": "653_CR138",
      "unstructured": "Rubtsov PM, Igudin EL, Pichugina MIu, Spirin PV, Prasolov VS, Tul´pakov AN. Characterization of new splicing mutation in steroid 21-hydroxylase gene. Bioorg Khim. 2011;37/6:815–20.",
      "volume": "37/6",
      "year": "2011"
    },
    {
      "author": "AE Billerbeck",
      "first-page": "4313",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR139",
      "unstructured": "Billerbeck AE, Mendonca BB, Pinto EM, Madureira G, Arnhold IJ, Bachega TA. Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect. J Clin Endocrinol Metab. 2002;87/9:4313–7.",
      "volume": "87/9",
      "year": "2002"
    },
    {
      "DOI": "10.1093/clinchem/44.10.2075",
      "author": "N Krone",
      "doi-asserted-by": "crossref",
      "first-page": "2075",
      "journal-title": "Clin Chem",
      "key": "653_CR140",
      "unstructured": "Krone N, Roscher AA, Schwarz HP, Braun A. Comprehensive analytical strategy for mutation screening in 21-hydroxylase deficiency. Clin Chem. 1998;44/10:2075–82.",
      "volume": "44/10",
      "year": "1998"
    },
    {
      "DOI": "10.1073/pnas.89.15.7232",
      "author": "A Wedell",
      "doi-asserted-by": "crossref",
      "first-page": "7232",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "653_CR141",
      "unstructured": "Wedell A, Ritzén EM, Haglund-Stengler B, Luthman H. Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc Natl Acad Sci U S A. 1992;89/15:7232–6.",
      "volume": "89/15",
      "year": "1992"
    },
    {
      "DOI": "10.1038/srep39082",
      "author": "CD Bruque",
      "doi-asserted-by": "crossref",
      "journal-title": "Sci Rep.",
      "key": "653_CR142",
      "unstructured": "Bruque CD, Delea M, Fernández CS, Orza JV, Taboas M, Buzzalino N, et al. Structure-based activity prediction of CYP21A2 stability variants: A survey of available gene variations. Sci Rep. 2016;6:39082.",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1073/pnas.85.12.4436",
      "author": "PC White",
      "doi-asserted-by": "crossref",
      "first-page": "4436",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "653_CR143",
      "unstructured": "White PC, Vitek A, Dupont B, New MI. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 1988;85/12:4436–40.",
      "volume": "85/12",
      "year": "1988"
    },
    {
      "DOI": "10.1073/pnas.1221133110",
      "author": "S Haider",
      "doi-asserted-by": "crossref",
      "first-page": "2605",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "653_CR144",
      "unstructured": "Haider S, Islam B, DʼAtri V, Sgobba M, Poojari C, Sun L, et al. Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia. Proc Natl Acad Sci USA. 2013;110/7:2605–10.",
      "volume": "110/7",
      "year": "2013"
    },
    {
      "DOI": "10.1002/iub.147",
      "author": "P Concolino",
      "doi-asserted-by": "crossref",
      "first-page": "229",
      "journal-title": "IUBMB Life.",
      "key": "653_CR145",
      "unstructured": "Concolino P, Vendittelli F, Mello E, Carelli Alinovi C, Minucci A, Carrozza C, et al. Two novel CYP21A2 missense mutations in Italian patients with 21-hydroxylase deficiency: Identification and functional characterisation. IUBMB Life. 2009;61/3:229–35.",
      "volume": "61/3",
      "year": "2009"
    },
    {
      "DOI": "10.1210/jc.2007-2646",
      "author": "FG Riepe",
      "doi-asserted-by": "crossref",
      "first-page": "2891",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR146",
      "unstructured": "Riepe FG, Hiort O, Grötzinger J, Sippell WG, Krone N, Holterhus PM. Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interaction. J Clin Endocrinol Metab. 2008;93/7:2891–5.",
      "volume": "93/7",
      "year": "2008"
    },
    {
      "author": "A Massimi",
      "first-page": "515",
      "journal-title": "Horm Metab Res",
      "key": "653_CR147",
      "unstructured": "Massimi A, Malaponti M, Federici L, Vinciguerra D, Manca Bitti ML, Vottero A, et al. Functional and structural analysis of four novel mutaions of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency. Horm Metab Res. 2014;46/7:515–20.",
      "volume": "46/7",
      "year": "2014"
    },
    {
      "DOI": "10.1210/jc.2012-3343",
      "author": "N Krone",
      "doi-asserted-by": "crossref",
      "first-page": "E346",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR148",
      "unstructured": "Krone N, Rose IT, Willis DS, Hodson J, Wild SH, Doherty EJ, et al. Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adreal Hyperplasia Adult Study Executive (CaHASE) cohort. J Clin Endocrinol Metab. 2013;98/2:E346–54.",
      "volume": "98/2",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pone.0092181",
      "author": "M Taboas",
      "doi-asserted-by": "crossref",
      "first-page": "e92181",
      "journal-title": "PLoS ONE.",
      "key": "653_CR149",
      "unstructured": "Taboas M, Gómez Acuña L, Scaia MF, Bruque CD, Buzzalino N, Stivel M, et al. Functional studies of p.R132C, p.R149C, p.M283V, p.E431K and a novel c.652-2A\u003eG mutations of the CYP21A2 gene. PLoS ONE. 2014;9/3:e92181.",
      "volume": "9/3",
      "year": "2014"
    },
    {
      "DOI": "10.1371/journal.pone.0015899",
      "author": "C Minutolo",
      "doi-asserted-by": "crossref",
      "first-page": "e15899",
      "journal-title": "PLoS ONE.",
      "key": "653_CR150",
      "unstructured": "Minutolo C, Nadra AD, Fernández C, Taboas M, Buzzalino N, Casali B, et al. Structure-based analysis of five novel disease-causing mutations in 21-hydroxylase-deficient patients. PLoS ONE. 2011;6/1:e15899.",
      "volume": "6/1",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1365-2265.2011.04275.x",
      "author": "M Barbaro",
      "doi-asserted-by": "crossref",
      "first-page": "766",
      "journal-title": "Clin Endocrinol (Oxf)",
      "key": "653_CR151",
      "unstructured": "Barbaro M, Soardi FC, de Mello MP, Wedell A, Lajic S. Functional studies of CYP21A2 mutants complement structural and clinical predictions of disease serverity in CAH. Clin Endocrinol (Oxf). 2012;76/5:766–8.",
      "volume": "76/5",
      "year": "2012"
    },
    {
      "DOI": "10.1530/EJE-12-0196",
      "author": "I Nermoen",
      "doi-asserted-by": "crossref",
      "first-page": "507",
      "journal-title": "Eur J Endocrinol",
      "key": "653_CR152",
      "unstructured": "Nermoen I, Brønstad I, Fougner KJ, Svartberg J, Øksnes M, Husebye ES, et al. Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. Eur J Endocrinol. 2012;167/4:507–16.",
      "volume": "167/4",
      "year": "2012"
    },
    {
      "author": "M Raisingani",
      "first-page": "867",
      "journal-title": "J Pediatr Endocrinol Metab",
      "key": "653_CR153",
      "unstructured": "Raisingani M, Contreras MF, Prasad K, Pappas JG, Kluge ML, Shah B, et al. Unusual phenotype of congenital adrenal hyperplasia (CAH) with a novel mutation of the CYP21A2 gene. J Pediatr Endocrinol Metab. 2016;29/7:867–71.",
      "volume": "29/7",
      "year": "2016"
    },
    {
      "DOI": "10.1111/cen.12309",
      "author": "X Chu",
      "doi-asserted-by": "crossref",
      "first-page": "927",
      "journal-title": "Clin Endocrinol (Oxf)",
      "key": "653_CR154",
      "unstructured": "Chu X, Ding H, Cui G, Xu Y, Wang DW, He Y. Functional consequences of a novel point mutation in the CYP21A2 gene identified in a Chinese Han patient with nonclassic 21-hydroxylase deficiency. Clin Endocrinol (Oxf). 2014;80/6:927–8.",
      "volume": "80/6",
      "year": "2014"
    },
    {
      "DOI": "10.1530/eje.1.02172",
      "author": "M Janner",
      "doi-asserted-by": "crossref",
      "first-page": "143",
      "journal-title": "Eur J Endocrinol",
      "key": "653_CR155",
      "unstructured": "Janner M, Pandey AV, Mullis PE, Flück CE. Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein. Eur J Endocrinol. 2006;155/1:143–51.",
      "volume": "155/1",
      "year": "2006"
    },
    {
      "DOI": "10.3343/alm.2015.35.5.535",
      "author": "G Hong",
      "doi-asserted-by": "crossref",
      "first-page": "535",
      "journal-title": "Ann Lab Med",
      "key": "653_CR156",
      "unstructured": "Hong G, Park HD, Choi R, Jin DK, Kim JH, Ki CS, et al. CYP21A2 mutation in Korean patients with congenital adrenal hyperplasia using complementary methods: sequencing after long-range PCR and restriction fragment length polymorphism analysis with multiple ligation-dependent probe amplification assay. Ann Lab Med. 2015;35/5:535–9.",
      "volume": "35/5",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s00109-006-0121-x",
      "author": "T Robins",
      "doi-asserted-by": "crossref",
      "first-page": "247",
      "journal-title": "J Mol Med (Berl)",
      "key": "653_CR157",
      "unstructured": "Robins T, Bellanne-Chantelot C, Barbaro M, Cabrol S, Wedell A, Lajic S. Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia. J Mol Med (Berl). 2007;85/3:247–55.",
      "volume": "85/3",
      "year": "2007"
    },
    {
      "DOI": "10.1210/jc.2009-1202",
      "author": "V Tardy",
      "doi-asserted-by": "crossref",
      "first-page": "1288",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR158",
      "unstructured": "Tardy V, Menassa R, Sulmont V, Lienhardt-Roussie A, Lecointre C, Brauner R, et al. Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patiens affected with 21-hydroxylase deficiency and in one carrier. J Clin Endocrinol Metab. 2010;95/3:1288–1300.",
      "volume": "95/3",
      "year": "2010"
    },
    {
      "DOI": "10.1210/jc.2006-0777",
      "author": "Y Grischuk",
      "doi-asserted-by": "crossref",
      "first-page": "4976",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR159",
      "unstructured": "Grischuk Y, Rubtsov P, Riepe FG, Grötzinger J, Beljelarskaia S, Prassolov V, et al. Four novel missense mutations in the CPY21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis. J Clin Endocrinol Metab. 2006;91/12:4976–80.",
      "volume": "91/12",
      "year": "2006"
    },
    {
      "DOI": "10.1002/(SICI)1098-1004(1999)13:2\u003c172::AID-HUMU17\u003e3.0.CO;2-N",
      "author": "SF Witchel",
      "doi-asserted-by": "crossref",
      "first-page": "172",
      "journal-title": "Hum Mutat.",
      "key": "653_CR160",
      "unstructured": "Witchel SF, Smith R, Suda-Hartman M. Identification of CYP21 mutations, one novel, by single strand conformational polymorphism (SSCP) analysis. Mutations in brief no. 218. Online. Hum Mutat. 1999;13/2:172.",
      "volume": "13/2",
      "year": "1999"
    },
    {
      "DOI": "10.1007/s00109-006-0043-7",
      "author": "M Barbaro",
      "doi-asserted-by": "crossref",
      "first-page": "521",
      "journal-title": "J Mol Med (Berl)",
      "key": "653_CR161",
      "unstructured": "Barbaro M, Baldazzi L, Balsamo A, Lajic S, Robins T, Barp L, et al. Functional studies of two novel and two rare mutations in the 21-hydroxylase gene. J Mol Med (Berl). 2006;84/6:521–8.",
      "volume": "84/6",
      "year": "2006"
    },
    {
      "DOI": "10.1073/pnas.85.5.1600",
      "author": "M Amor",
      "doi-asserted-by": "crossref",
      "first-page": "1600",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "653_CR162",
      "unstructured": "Amor M, Parker KL, Globerman H, New MI, White PC. Mutation in the CYP21B gene (Ile-172–Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 1988;85/5:1600–4.",
      "volume": "85/5",
      "year": "1988"
    },
    {
      "DOI": "10.1016/j.metabol.2017.03.003",
      "author": "P Concolino",
      "doi-asserted-by": "crossref",
      "first-page": "46",
      "journal-title": "Metabolism.",
      "key": "653_CR163",
      "unstructured": "Concolino P, Rizza R, Costella A, Carrozza C, Zuppi C, Capoluongo E. CYP21A2 intronic variants causing 21-hydroxylase deficiency. Metabolism. 2017;71:46–51.",
      "volume": "71",
      "year": "2017"
    },
    {
      "DOI": "10.1210/jc.2002-021681",
      "author": "NM Stikkelbroeck",
      "doi-asserted-by": "crossref",
      "first-page": "3852",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR164",
      "unstructured": "Stikkelbroeck NM, Hoefsloot LH, de Wijs IJ, Otten BJ, Hermus AR, Sistermans EA. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab. 2003;88/8:3852–9.",
      "volume": "88/8",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.cca.2016.11.037",
      "author": "R Khajuria",
      "doi-asserted-by": "crossref",
      "first-page": "189",
      "journal-title": "Clin Chim Acta",
      "key": "653_CR165",
      "unstructured": "Khajuria R, Walia R, Bhansali A, Prasad R. The spectrum of CYP21A2 mutations in Congenital Adrenal Hyperplasia in an Indian cohort. Clin Chim Acta. 2017;464:189–94.",
      "volume": "464",
      "year": "2017"
    },
    {
      "DOI": "10.1016/0076-6879(91)06087-J",
      "author": "Y Higashi",
      "doi-asserted-by": "crossref",
      "first-page": "166",
      "journal-title": "Methods Enzymol",
      "key": "653_CR166",
      "unstructured": "Higashi Y, Fujii-Kuriyama Y. Functional analysis of mutant P450(C21) genes in COS cell expression system. Methods Enzymol. 1991;206:166–73.",
      "volume": "206",
      "year": "1991"
    },
    {
      "DOI": "10.1016/j.metabol.2011.08.008",
      "author": "P Concolino",
      "doi-asserted-by": "crossref",
      "first-page": "519",
      "journal-title": "Metabolism.",
      "key": "653_CR167",
      "unstructured": "Concolino P, Mello E, Patrosso MC, Penco S, Zuppi C, Capoluongo E. p.H282N and p.Y191H: 2 novel CPY21A2 mutations in Italian congenital adrenal hyperplasia patients. Metabolism. 2012;61/4:519–24.",
      "volume": "61/4",
      "year": "2012"
    },
    {
      "DOI": "10.1074/jbc.273.11.6163",
      "author": "A Nikoshkov",
      "doi-asserted-by": "crossref",
      "first-page": "6163",
      "journal-title": "J Biol Chem",
      "key": "653_CR168",
      "unstructured": "Nikoshkov A, Lajic S, Vlamis-Gardikas A, Tranebjaerg L, Holst M, Wedell A, et al. Naturally occuring mutants of human steroid 21-hydroxylase (P450c21) pinpoint residues important for enzyme activity and stability. J Biol Chem. 1998;273/11:6163–5.",
      "volume": "273/11",
      "year": "1998"
    },
    {
      "author": "M Niceta",
      "first-page": "847",
      "journal-title": "J Endocrinol Invest",
      "key": "653_CR169",
      "unstructured": "Niceta M, Bono M, Fabiano C, Pojero F, Niceta F, Sammarco P, et al. A large view of CYP21 locus among Sicilians and other populations: identification of a novel CYP21A2 variant in Sicily. J Endocrinol Invest. 2011;34/11:847–54.",
      "volume": "34/11",
      "year": "2011"
    },
    {
      "DOI": "10.1056/NEJM198807073190104",
      "author": "PW Speiser",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "journal-title": "N Engl J Med",
      "key": "653_CR170",
      "unstructured": "Speiser PW, New MI, White PC. Molecular genetic analysis of nonclassic steriod 21-hydroxylase deficiency associated with HLA-B14,DR1. N Engl J Med. 1988;319/1:19–23.",
      "volume": "319/1",
      "year": "1988"
    },
    {
      "author": "R Girgis",
      "first-page": "765",
      "journal-title": "J Pediatr Endocrinol Metab",
      "key": "653_CR171",
      "unstructured": "Girgis R, Ajamian F, Metcalfe P. A previously undescribed mutation detected by sequence analysis of CYP21A2 gene in an infant with salt wasting congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 2013;26/7-8:765–6.",
      "volume": "26/7-8",
      "year": "2013"
    },
    {
      "author": "P Concolino",
      "first-page": "559",
      "journal-title": "Hum Genet.",
      "key": "653_CR172",
      "unstructured": "Concolino P, Santonocito C, Minucci A, Carrozza C, Zuppi C, Capoluongo E, et al. Novel human pathological mutations. Gene Symbol: CYP21A2. Disease: Non-classic 21-hydroxylase deficiency. Hum Genet. 2007;122/5:559.",
      "volume": "122/5",
      "year": "2007"
    },
    {
      "DOI": "10.1055/s-2005-872841",
      "author": "N Krone",
      "doi-asserted-by": "crossref",
      "first-page": "111",
      "journal-title": "Exp Clin Endocrinol Diabetes",
      "key": "653_CR173",
      "unstructured": "Krone N, Riepe FG, Partsch CJ, Vorhoff W, Brämswig J, Sippell WG. Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Exp Clin Endocrinol Diabetes. 2006;114/3:111–7.",
      "volume": "114/3",
      "year": "2006"
    },
    {
      "DOI": "10.1034/j.1399-0004.2002.620213.x",
      "author": "B Ezquieta",
      "doi-asserted-by": "crossref",
      "first-page": "181",
      "journal-title": "Clin Genet",
      "key": "653_CR174",
      "unstructured": "Ezquieta B, Cueva E, Oyarzábal M, Oliver A, Varela JM, Jariego C. Gene conversion (655G splicing mutation) and the founder effect (Gln318Stop) contribute to the most frequent severe point mutations in congenital adrenal hyperplasia (21-hydroxylase deficiency) in the Spanish population. Clin Genet. 2002;62/2:181–8.",
      "volume": "62/2",
      "year": "2002"
    },
    {
      "DOI": "10.1007/BF03345586",
      "author": "H Falhammar",
      "doi-asserted-by": "crossref",
      "first-page": "176",
      "journal-title": "J Endocrinol Invest",
      "key": "653_CR175",
      "unstructured": "Falhammar H, Thorén M, Hagenfeldt K. A 31-year-old woman with infertility and polycystic ovaries diagnosed with non-classic congenital adrenal hyperplasia due to anovel CYP21 mutation. J Endocrinol Invest. 2008;31/2:176–80.",
      "volume": "31/2",
      "year": "2008"
    },
    {
      "DOI": "10.1210/jc.2004-1937",
      "author": "T Robins",
      "doi-asserted-by": "crossref",
      "first-page": "2148",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR176",
      "unstructured": "Robins T, Barbaro M, Lajic S, Wedell A. Not all amino acid substitutions of the common cluster E6 mutation in CYP21 cause congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2005;90/4:2148–53.",
      "volume": "90/4",
      "year": "2005"
    },
    {
      "DOI": "10.1097/PDM.0b013e31825df903",
      "author": "P Concolino",
      "doi-asserted-by": "crossref",
      "first-page": "48",
      "journal-title": "Diagn Mol Pathol",
      "key": "653_CR177",
      "unstructured": "Concolino P, Mello E, Zuppi C, Toscano V, Capoluongo E. CYP21A2 p.E238 deletion as result of multiple microconversion events: a genetic study on an Italian congenital adrenal hyperplasia (CAH) family. Diagn Mol Pathol. 2013;22/1:48–51.",
      "volume": "22/1",
      "year": "2013"
    },
    {
      "DOI": "10.1515/CCLM.2010.239",
      "author": "P Concolino",
      "doi-asserted-by": "crossref",
      "first-page": "1057",
      "journal-title": "Clin Chem Lab Med",
      "key": "653_CR178",
      "unstructured": "Concolino P, Mello E, Zuppi C, Capoluongo E. Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations. Clin Chem Lab Med. 2010;48/8:1057–62.",
      "volume": "48/8",
      "year": "2010"
    },
    {
      "author": "KY Loke",
      "first-page": "179",
      "journal-title": "Horm Res.",
      "key": "653_CR179",
      "unstructured": "Loke KY, Lee YS, Lee WW, Poh LK. Molecular analysis of CYP-21 mutations for congenital adrenal hyperplasia in Singapore. Horm Res. 2001;55/4:179–84.",
      "volume": "55/4",
      "year": "2001"
    },
    {
      "DOI": "10.1002/humu.20926",
      "author": "C Bleicken",
      "doi-asserted-by": "crossref",
      "first-page": "E443",
      "journal-title": "Hum Mutat.",
      "key": "653_CR180",
      "unstructured": "Bleicken C, Loidi L, Dhir V, Parajes C, Quinteiro C, Dominguez F, et al. Functional characterization of three CYP21A2 sequence variants (p.A265V, p.W302S, p.D322G) employing a yeast co-expression system. Hum Mutat. 2009;30/2:E443–50.",
      "volume": "30/2",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s100380050167",
      "author": "A Asanuma",
      "doi-asserted-by": "crossref",
      "first-page": "312",
      "journal-title": "J Hum Genet",
      "key": "653_CR181",
      "unstructured": "Asanuma A, Ohura T, Ogawa E, Sato S, Igarashi Y, Matsubara Y, et al. Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency. J Hum Genet. 1999;44/5:312–7.",
      "volume": "44/5",
      "year": "1999"
    },
    {
      "author": "DA Wu",
      "first-page": "519",
      "journal-title": "J Clin Invest",
      "key": "653_CR182",
      "unstructured": "Wu DA, Chung BC. Mutations of P450c21 (steriod 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial or no loss of enzymatic activity, respectively. J Clin Invest. 1991;88/2:519–23.",
      "volume": "88/2",
      "year": "1991"
    },
    {
      "DOI": "10.1002/humu.1380050205",
      "author": "B Barbat",
      "doi-asserted-by": "crossref",
      "first-page": "126",
      "journal-title": "Hum Mutat.",
      "key": "653_CR183",
      "unstructured": "Barbat B, Bogyo A, Raux-Demay MC, Kuttenn F, Boué J, Simon-Bouy B, et al. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency. Hum Mutat. 1995;5/2:126–30.",
      "volume": "5/2",
      "year": "1995"
    },
    {
      "DOI": "10.1056/NEJM198807073190104",
      "author": "PW Speiser",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "journal-title": "N Engl J Med",
      "key": "653_CR184",
      "unstructured": "Speiser PW, New MI, White PC. Molecular genetic analysis of nonclassic steriod 21-hydroxylase deficiency associated with HLA-B14,DR1. N Engl J Med. 1988;319/1:19–23.",
      "volume": "319/1",
      "year": "1988"
    },
    {
      "DOI": "10.1111/j.1651-2227.2002.tb02851.x",
      "author": "B Ezquieta",
      "doi-asserted-by": "crossref",
      "first-page": "892",
      "journal-title": "Acta Paediatr",
      "key": "653_CR185",
      "unstructured": "Ezquieta B, Cueva E, Varela J, Oliver A, Fernández J, Jariego C. Non-classical 21-hydroxylase deficiency in children: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations. Acta Paediatr. 2002;91/8:892–8.",
      "volume": "91/8",
      "year": "2002"
    },
    {
      "DOI": "10.1530/EJE-16-0171",
      "author": "DF de Carvalho",
      "doi-asserted-by": "crossref",
      "first-page": "107",
      "journal-title": "Eur J Endocrinol",
      "key": "653_CR186",
      "unstructured": "de Carvalho DF, Miranda MC, Gomes LG, Madureira G, Marcondes JA, Billerbeck AE, et al. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction. Eur J Endocrinol. 2016;175/2:107–16.",
      "volume": "175/2",
      "year": "2016"
    },
    {
      "DOI": "10.1002/humu.20926",
      "author": "C Bleicken",
      "doi-asserted-by": "publisher",
      "first-page": "E443",
      "issue": "Feb",
      "journal-title": "Hum Mutat.",
      "key": "653_CR187",
      "unstructured": "Bleicken C, Loidi L, Dhir V, Parajes S, Quinteiro C, Dominguez F, et al. Functional characterization of three CYP21A2 sequence variants (p.A265V, p.W302S, p.D322G) employing a yeast co-expression system. Hum Mutat. 2009;30(Feb):E443–50. https://doi.org/10.1002/humu.20926.",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1002/(SICI)1098-1004(1997)9:4\u003c363::AID-HUMU11\u003e3.0.CO;2-0",
      "author": "A Levo",
      "doi-asserted-by": "crossref",
      "first-page": "363",
      "journal-title": "Hum Mutat.",
      "key": "653_CR188",
      "unstructured": "Levo A, Partanen J. Novel nonsense mutation (W302X) in the steroid 21-hydroxylase gene of a Finnish patient with the salt-wasting form of congenital adrenal hyperplasia. Hum Mutat. 1997;9/4:363–5.",
      "volume": "9/4",
      "year": "1997"
    },
    {
      "DOI": "10.1210/jcem.87.6.8525",
      "author": "S Lajić",
      "doi-asserted-by": "crossref",
      "first-page": "2824",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR189",
      "unstructured": "Lajić S, Clauin S, Robins T, Vexiau P, Blanché H, Bellanne-Chantelot C, et al. Novel mutations in CYP21 detected in individuals with hyperandrogenism. J Clin Endocrinol Metab. 2002;87/6:2824–9.",
      "volume": "87/6",
      "year": "2002"
    },
    {
      "DOI": "10.1093/hmg/2.5.499",
      "author": "A Wedell",
      "doi-asserted-by": "crossref",
      "first-page": "499",
      "journal-title": "Hum Mol Genet",
      "key": "653_CR190",
      "unstructured": "Wedell A, Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Hum Mol Genet. 1993;2/5:499–504.",
      "volume": "2/5",
      "year": "1993"
    },
    {
      "author": "ML Ordoñez-Sánchez",
      "first-page": "170",
      "journal-title": "Hum Genet.",
      "key": "653_CR191",
      "unstructured": "Ordoñez-Sánchez ML, Ramírez-Jiménez S, López-Gutierrez AU, Riba L, Gamboa-Cardiel S, Cerrillo-Hinojosa M, et al. Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: identification of possible new mutations and high prevalence of apparent germ-line mutations. Hum Genet. 1998;102/2:170–7.",
      "volume": "102/2",
      "year": "1998"
    },
    {
      "DOI": "10.1530/eje.1.01944",
      "author": "V Dolzan",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "journal-title": "Eur J Endocrinol",
      "key": "653_CR192",
      "unstructured": "Dolzan V, Sólyom J, Fekete G, Kovács J, Rakosnikova V, Votava F, et al. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol. 2005;153/1:99–106.",
      "volume": "153/1",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s004390050821",
      "author": "HH Lee",
      "doi-asserted-by": "crossref",
      "first-page": "304",
      "journal-title": "Hum Genet.",
      "key": "653_CR193",
      "unstructured": "Lee HH, Chao HT, Lee YJ, Shu SG, Chao MC, Kuo JM, et al. Identification of four novel mutations in the CYP21 gene in congenital adrenal hyperplasia in the Chinese. Hum Genet. 1998;103/3:304–10.",
      "volume": "103/3",
      "year": "1998"
    },
    {
      "DOI": "10.1210/jcem.86.1.7131",
      "author": "C Deneux",
      "doi-asserted-by": "crossref",
      "first-page": "207",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR194",
      "unstructured": "Deneux C, Tardy V, Dib A, Mornet E, Billaud L, Charron D, et al. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2001;86/1:207–13.",
      "volume": "86/1",
      "year": "2001"
    },
    {
      "DOI": "10.1007/s00439-005-1339-3",
      "author": "J Bojunga",
      "doi-asserted-by": "crossref",
      "first-page": "558",
      "journal-title": "Hum Genet.",
      "key": "653_CR195",
      "unstructured": "Bojunga J, Welsch C, Antes I, Albrecht M, Lengauer T, Zeuzem S. Structural and functional analysis of a novel mutation of CP21B in a heterozygote carrier of 21-hydroxylase deficiency. Hum Genet. 2005;117/6:558–64.",
      "volume": "117/6",
      "year": "2005"
    },
    {
      "DOI": "10.1172/JCI113562",
      "author": "H Globerman",
      "doi-asserted-by": "crossref",
      "first-page": "139",
      "journal-title": "J Clin Invest",
      "key": "653_CR196",
      "unstructured": "Globerman H, Amor M, Parker KL, New MI, White PC. Nonsense mutation causing steroid 21-hydroxylase deficiency. J Clin Invest. 1988;82/1:139–44.",
      "volume": "82/1",
      "year": "1988"
    },
    {
      "DOI": "10.1016/S0025-7753(06)72688-4",
      "author": "C Bernal González",
      "doi-asserted-by": "crossref",
      "first-page": "617",
      "journal-title": "Med Clin (Barc).",
      "key": "653_CR197",
      "unstructured": "Bernal González C, Fernández Salas C, Martínez S, Ezquieta Zubicaray B. [Premature androgenetic alopecia in adult male with nonclassic 21-OH deficiency. A novel nonsense CYP21A2 mutation (Y336X) in 2 affected siblings]. Med Clin (Barc). 2006;127/16:617–21.",
      "volume": "127/16",
      "year": "2006"
    },
    {
      "author": "A Helmberg",
      "first-page": "1318",
      "journal-title": "Mol Endocrinol.",
      "key": "653_CR198",
      "unstructured": "Helmberg A, Tusie-Luna MT, Tabarelli M, Kofler R, White PC. R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions. Mol Endocrinol. 1992;6/8:1318–22.",
      "volume": "6/8",
      "year": "1992"
    },
    {
      "DOI": "10.1210/jc.2003-030123",
      "author": "A Balsamo",
      "doi-asserted-by": "crossref",
      "first-page": "5680",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR199",
      "unstructured": "Balsamo A, Cicognani A, Baldazzi L, Barbaro M, Baronio F, Gennari M, et al. CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2003;88/12:5680–8.",
      "volume": "88/12",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s00109-005-0655-3",
      "author": "N Krone",
      "doi-asserted-by": "crossref",
      "first-page": "561",
      "journal-title": "J Mol Med (Berl)",
      "key": "653_CR200",
      "unstructured": "Krone N, Riepe FG, Grötzinger J, Partsch CJ, Brämswig J, Sippell WG. The residue E351 is essential for the activity of human 21-hydroxylase: evidence from a naturally occuring novel point mutation compared with artificial mutants generated by single amino acid substitutions. J Mol Med (Berl). 2005;83/7:561–8.",
      "volume": "83/7",
      "year": "2005"
    },
    {
      "author": "F Abid",
      "first-page": "1707",
      "journal-title": "Clin Chem Lab Med",
      "key": "653_CR201",
      "unstructured": "Abid F, Tardy V, Gaouzi A, El Hessni A, Morel Y, Chabraoui L. CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation. Clin Chem Lab Med. 2008;46/12:1707–13.",
      "volume": "46/12",
      "year": "2008"
    },
    {
      "author": "S Dubey",
      "first-page": "194",
      "journal-title": "Indian J Med Res",
      "key": "653_CR202",
      "unstructured": "Dubey S, Tardy V, Chowdhury MR, Gupta N, Jain V, Deka D, et al. Prenatal diagnosis of steroid 21-hydroxylase-deficient congenital adrenal hyperplasia: Experience from a tertiary care centre in India. Indian J Med Res. 2017;145/2:194–202.",
      "volume": "145/2",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S0021-9258(19)39804-7",
      "author": "SH Chiou",
      "doi-asserted-by": "crossref",
      "first-page": "3549",
      "journal-title": "J Biol Chem",
      "key": "653_CR203",
      "unstructured": "Chiou SH, Hu MC, Chung BC. A missense mutation at Ile172–Asn or Arg356–Trp causes steroid 21-hydroxylase deficiency. J Biol Chem. 1990;265/6:3549–52.",
      "volume": "265/6",
      "year": "1990"
    },
    {
      "DOI": "10.1007/s004390050394",
      "author": "A Levo",
      "doi-asserted-by": "crossref",
      "first-page": "488",
      "journal-title": "Hum Genet.",
      "key": "653_CR204",
      "unstructured": "Levo A, Partanen J. Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles. Hum Genet. 1997;99/4:488–97.",
      "volume": "99/4",
      "year": "1997"
    },
    {
      "DOI": "10.1007/s004390050436",
      "author": "S Lajic",
      "doi-asserted-by": "crossref",
      "first-page": "704",
      "journal-title": "Hum Genet.",
      "key": "653_CR205",
      "unstructured": "Lajic S, Levo A, Nikoshkov A, Lundberg Y, Partanen J, Wedell A. A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction. Hum Genet. 1997;99/6:704–9.",
      "volume": "99/6",
      "year": "1997"
    },
    {
      "author": "S Menabò",
      "first-page": "298",
      "journal-title": "J Endocrinol Invest",
      "key": "653_CR206",
      "unstructured": "Menabò S, Balsamo A, Baldazzi L, Barbaro M, Nicoletti A, Conti V, et al. A sequence variation in 3ˈUTR of CYP21A2 gene correlates with a mild form of congenital adrenal hyperplasia. J Endocrinol Invest. 2012;35/3:298–305.",
      "volume": "35/3",
      "year": "2012"
    },
    {
      "DOI": "10.1002/pd.167",
      "author": "A Levo",
      "doi-asserted-by": "crossref",
      "first-page": "885",
      "journal-title": "Prenat Diagn.",
      "key": "653_CR207",
      "unstructured": "Levo A, Partanen J. Novel mutations in the human CYP21 gene. Prenat Diagn. 2001;21/10:885–9.",
      "volume": "21/10",
      "year": "2001"
    },
    {
      "DOI": "10.1002/(SICI)1098-1004(1997)9:2\u003c181::AID-HUMU12\u003e3.0.CO;2-Z",
      "author": "L Kirby-Keyser",
      "doi-asserted-by": "crossref",
      "first-page": "181",
      "journal-title": "Hum Mutat.",
      "key": "653_CR208",
      "unstructured": "Kirby-Keyser L, Porter CC, Donohoue PA. E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Mutat. 1997;9/2:181–2.",
      "volume": "9/2",
      "year": "1997"
    },
    {
      "DOI": "10.1007/BF03346522",
      "author": "M Wasniewska",
      "doi-asserted-by": "crossref",
      "first-page": "633",
      "journal-title": "J Endocrinol Invest",
      "key": "653_CR209",
      "unstructured": "Wasniewska M, Mirabelli S, Baldazzi L, Salzano G, Messina MF, Lombardo F, et al. Novel mutation of CYP21A2 gene (N387K) affecting a non-conserved amino acid residue in exon 9. J Endocrinol Invest. 2009;32/7:633.",
      "volume": "32/7",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1365-2265.2007.02886.x",
      "author": "A Baradaran-Heravi",
      "doi-asserted-by": "crossref",
      "first-page": "335",
      "journal-title": "Clin Endocrinol (Oxf)",
      "key": "653_CR210",
      "unstructured": "Baradaran-Heravi A, Vakili R, Robins T, Carlsson J, Ghaemi N, Aʼrabi A, et al. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran. Clin Endocrinol (Oxf). 2007;67/3:335–41.",
      "volume": "67/3",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.metabol.2010.03.012",
      "author": "N Katsumata",
      "doi-asserted-by": "crossref",
      "first-page": "1628",
      "journal-title": "Metabolism.",
      "key": "653_CR211",
      "unstructured": "Katsumata N, Shinagawa T, Horikawa R, Fujikura K. Novel intronic CYP21A2 mutation in a Japanese patient with classic salt-wasting steroid 21-hydroxylase deficiency. Metabolism. 2010;59/11:1628–32.",
      "volume": "59/11",
      "year": "2010"
    },
    {
      "DOI": "10.1089/gtmb.2010.0131",
      "author": "Y Yu",
      "doi-asserted-by": "publisher",
      "first-page": "137",
      "issue": "Mar",
      "journal-title": "Genet Test Mol Biomarkers.",
      "key": "653_CR212",
      "unstructured": "Yu Y, Wang J, Huang X, Wang Y, Yang P, Li J, et al. Molecular characterization of 25 Chinese pedigrees with 21-hydroxylase deficiency. Genet Test Mol Biomarkers. 2011;15(Mar):137–42. https://doi.org/10.1089/gtmb.2010.0131.",
      "volume": "15",
      "year": "2011"
    },
    {
      "author": "AE Billerbeck",
      "first-page": "2870",
      "journal-title": "J Clin Enocrinol Metab",
      "key": "653_CR213",
      "unstructured": "Billerbeck AE, Bachega TA, Frazetto ET, Nishi MY, Goldberg AC, Marin ML, et al. A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency. J Clin Enocrinol Metab. 1999;84/8:2870–2.",
      "volume": "84/8",
      "year": "1999"
    },
    {
      "DOI": "10.1210/jcem.86.10.7898",
      "author": "SM Baumgartner-Parzer",
      "doi-asserted-by": "crossref",
      "first-page": "4771",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "653_CR214",
      "unstructured": "Baumgartner-Parzer SM, Schulze E, Waldhäusl W, Pauschenwein S, Rondot S, Nowotny P, et al. Mutational spectrum of the steroid 21-hyxdroxylase gene in Austria: identification of a novel missense mutation. J Clin Endocrinol Metab. 2001;86/10:4771–5.",
      "volume": "86/10",
      "year": "2001"
    },
    {
      "author": "L Dain",
      "first-page": "363",
      "journal-title": "Hum Genet.",
      "key": "653_CR215",
      "unstructured": "Dain L, Minutolo C, Buzzalino N, Belli S, Oneto A, Charreau E, et al. Gene symbol: CYP21A2. Disease: adrenal hyperplasia, CYP 21. Hum Genet. 2006;119/3:363.",
      "volume": "119/3",
      "year": "2006"
    },
    {
      "author": "B Carvalho",
      "first-page": "535",
      "journal-title": "Exp Clin Endocrinol Diabetes",
      "key": "653_CR216",
      "unstructured": "Carvalho B, Pereira M, Marques CJ, Carvalho D, Leão M, Oliveira JP, et al. Comprehensive genetic analysis and structural characterization of CYP21A2 mutations in CAH patients. Exp Clin Endocrinol Diabetes. 2012;120/9:535–9.",
      "volume": "120/9",
      "year": "2012"
    },
    {
      "author": "D Owerbach",
      "first-page": "1211",
      "journal-title": "Mol Endocrinol.",
      "key": "653_CR217",
      "unstructured": "Owerbach D, Sherman L, Ballard AL, Azziz R. Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency. Mol Endocrinol. 1992;6/8:1211–5.",
      "volume": "6/8",
      "year": "1992"
    },
    {
      "author": "H Wang",
      "first-page": "681",
      "journal-title": "Zhonghua Yi Xue Chuan Xue Za Zhi",
      "key": "653_CR218",
      "unstructured": "Wang H, Jiang L, Wang PP, Zhou HB, Wang JL, Song LL. [Mutation analysis in families with 21-hydroxylase deficiency]. Zhonghua Yi Xue Chuan Xue Za Zhi. 2007;24/6:681–4.",
      "volume": "24/6",
      "year": "2007"
    },
    {
      "author": "ML Ordoñez-Sánchez",
      "first-page": "170",
      "journal-title": "Hum Genet.",
      "key": "653_CR219",
      "unstructured": "Ordoñez-Sánchez ML, Ramírez-Jiménez S, López-Gutierrez AU, Riba L, Gamboa-Cardiel S, Cerrillo-Hinojosa M, et al. Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: identification of possible new mutations and high prevalence of apparent germ-line mutations. Hum Genet. 1998;102/2:170–7.",
      "volume": "102/2",
      "year": "1998"
    },
    {
      "DOI": "10.1007/BF03345346",
      "author": "G Di Pasquale",
      "doi-asserted-by": "crossref",
      "first-page": "1038",
      "journal-title": "J Endocrinol Invest.",
      "key": "653_CR220",
      "unstructured": "Di Pasquale G, Wasniewska M, Caruso M, Salzano G, Coco M, Lombardo F, et al. Salt wasting phenotype in a compound heterocygous girl with P482S mutation associated with a novel mutation of CYP21 gene (Q481P). J Endocrinol Invest. 2005;28/11:1038–9.",
      "volume": "28/11",
      "year": "2005"
    },
    {
      "DOI": "10.1210/jc.2003-031630",
      "author": "M Barbaro",
      "doi-asserted-by": "crossref",
      "first-page": "2402",
      "journal-title": "J Clin Endocrinol Metab.",
      "key": "653_CR221",
      "unstructured": "Barbaro M, Lajic S, Baldazzi L, Balsamo A, Pirazzoli P, Cicognani A, et al. Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2004;89/5:2402–7.",
      "volume": "89/5",
      "year": "2004"
    },
    {
      "author": "A Wedell",
      "first-page": "236",
      "journal-title": "Hum Genet.",
      "key": "653_CR222",
      "unstructured": "Wedell A, Luthman H. Steroid 21-hydroxylase (P450c21): a new allele and spread of mutations through the pseudogene. Hum Genet. 1993;91/3:236–40.",
      "volume": "91/3",
      "year": "1993"
    },
    {
      "DOI": "10.1002/humu.1380030408",
      "author": "PC White",
      "doi-asserted-by": "crossref",
      "first-page": "373",
      "journal-title": "Hum Mutat.",
      "key": "653_CR223",
      "unstructured": "White PC, Tusie-Luna MT, New MI, Speiser PW. Mutations in steroid 21-hydroxylase (CYP21). Hum Mutat. 1994;3/4:373–8.",
      "volume": "3/4",
      "year": "1994"
    },
    {
      "DOI": "10.1155/2017/8984365",
      "doi-asserted-by": "publisher",
      "key": "653_CR224",
      "unstructured": "Neocleous V, Fanis P, Toumba M, Phedonos AAP, Picolos M, Andreou E, et al. Variations in the 3ʼUTR of the CYP21A2 Gene in Heterozygous Females with Hyperandrogenaemia. Int J Endocrinol. 2017; https://doi.org/10.1155/2017/8984365."
    },
    {
      "DOI": "10.1530/EJE-11-0828",
      "author": "H Falhammar",
      "doi-asserted-by": "crossref",
      "first-page": "441",
      "journal-title": "Eur J Endocrinol",
      "key": "653_CR225",
      "unstructured": "Falhammar H, Nyström HF, Ekström U, Granberg S, Wedell A, Thorén M. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol. 2012;166:441–9.",
      "volume": "166",
      "year": "2012"
    },
    {
      "DOI": "10.6065/apem.2015.20.3.155",
      "author": "MK Yu",
      "doi-asserted-by": "crossref",
      "first-page": "155",
      "journal-title": "Ann Pediatr Endocrinol Metab",
      "key": "653_CR226",
      "unstructured": "Yu MK, Jung MK, Kim KE, Kwon AR, Chae HW, Kim DH, et al. Clinical manifestations of testicular adrenal rest tumor in males with congenital adrenal hyperplasia. Ann Pediatr Endocrinol Metab. 2015;20:155–61.",
      "volume": "20",
      "year": "2015"
    },
    {
      "DOI": "10.1093/nar/gkx1098",
      "author": "DR Zerbino",
      "doi-asserted-by": "crossref",
      "first-page": "D754",
      "journal-title": "Nucleic Acids Res",
      "key": "653_CR227",
      "unstructured": "Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J, et al. Ensembl 2018. Nucleic Acids Res. 2018;46:D754–61.",
      "volume": "46",
      "year": "2018"
    }
  ],
  "reference-count": 227,
  "references-count": 227,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-020-0653-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "28"
}